BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 2019;40:3297-317. [PMID: 31504452 DOI: 10.1093/eurheartj/ehz641] [Cited by in Crossref: 268] [Cited by in F6Publishing: 199] [Article Influence: 134.0] [Reference Citation Analysis]
Number Citing Articles
1 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JG, Coats AJ, Crespo-leiro MG, Farmakis D, Gilard M, Heyman S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CS, Lyon AR, Mcmurray JJ, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GM, Ruschitzka F, Skibelund AK. Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.11.027] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lüscher TF. HFpEF: an enigma being slowly but surely unravelled. Eur Heart J 2019;40:3659-62. [PMID: 31786589 DOI: 10.1093/eurheartj/ehz848] [Reference Citation Analysis]
3 Wintrich J, Berger AK, Bewarder Y, Emrich I, Slawik J, Böhm M. [Update on diagnostics and treatment of heart failure]. Herz 2021. [PMID: 34463784 DOI: 10.1007/s00059-021-05062-x] [Reference Citation Analysis]
4 Wang R, Fang Z, Wang H, Schoepf UJ, Emrich T, Giovagnoli D, Biles E, Zhou Z, Du Z, Liu T, Xu L. Quantitative analysis of three-dimensional left ventricular global strain using coronary computed tomography angiography in patients with heart failure: Comparison with 3T cardiac MR. Eur J Radiol 2021;135:109485. [PMID: 33401113 DOI: 10.1016/j.ejrad.2020.109485] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Trauzeddel RF, Nordine M, Groesdonk HV, Michels G, Pfister R, Reuter DA, Scheeren TWL, Berger C, Treskatsch S. [Perioperative optimization using hemodynamically focused echocardiography in high-risk patients-A practice guide]. Anaesthesist 2021. [PMID: 33660043 DOI: 10.1007/s00101-021-00934-7] [Reference Citation Analysis]
6 Fujisawa T, Kimura T, Ikemura N, Miyama H, Katsumata Y, Ueda I, Tanimoto K, Kanki H, Fukuda K, Kohsaka S, Takatsuki S. Effect of Tricuspid Regurgitation on the Reported Quality of Life and Subsequent Outcomes in Patients With Atrial Fibrillation. J Am Heart Assoc 2022;:e022713. [PMID: 35383465 DOI: 10.1161/JAHA.121.022713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hashemi D, Motzkus L, Blum M, Kraft R, Tanacli R, Tahirovic E, Doeblin P, Zieschang V, Zamani SM, Kelm M, Kuehne T, Pieske B, Alogna A, Edelmann F, Duengen HD, Kelle S. Myocardial deformation assessed among heart failure entities by cardiovascular magnetic resonance imaging. ESC Heart Fail 2021;8:890-7. [PMID: 33539681 DOI: 10.1002/ehf2.13193] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Del Buono MG, Iannaccone G, Scacciavillani R, Carbone S, Camilli M, Niccoli G, Borlaug BA, Lavie CJ, Arena R, Crea F, Abbate A. Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence. Progress in Cardiovascular Diseases 2020;63:570-84. [DOI: 10.1016/j.pcad.2020.04.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
9 Churchill TW, Li SX, Curreri L, Zern EK, Lau ES, Liu EE, Farrell R, Shoenike MW, Sbarbaro J, Malhotra R, Nayor M, Tschöpe C, de Boer RA, Lewis GD, Ho JE. Evaluation of 2 Existing Diagnostic Scores for Heart Failure With Preserved Ejection Fraction Against a Comprehensively Phenotyped Cohort. Circulation 2021;143:289-91. [PMID: 33464963 DOI: 10.1161/CIRCULATIONAHA.120.050757] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Kanagala P, Arnold JR, Khan JN, Singh A, Gulsin GS, Eltayeb M, Gupta P, Squire IB, McCann GP, Ng LL. Fibroblast-growth-factor-23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes. ESC Heart Fail 2020. [PMID: 32935918 DOI: 10.1002/ehf2.13020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Seoudy H, Eberstein M, Frank J, Thomann M, Puehler T, Lutter G, Lutz M, Bramlage P, Frey N, Saad M, Frank D. HFA‐PEFF score: prognosis in patients with preserved ejection fraction after transcatheter aortic valve implantation. ESC Heart Failure. [DOI: 10.1002/ehf2.13774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Naser JA, Pislaru S, Stan MN, Lin G. Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease. Heart 2021:heartjnl-2021-319752. [PMID: 34489313 DOI: 10.1136/heartjnl-2021-319752] [Reference Citation Analysis]
13 Lüscher TF. Cardiovascular issues in women: expanding diversity in medicine. Eur Heart J 2019;40:3807-11. [PMID: 31837148 DOI: 10.1093/eurheartj/ehz878] [Reference Citation Analysis]
14 He S, Zhu H, Zhang J, Wu X, Zhao L, Yang X. Proteomic analysis of epicardial adipose tissue from heart disease patients with concomitant heart failure with preserved ejection fraction. Int J Cardiol 2022;362:118-25. [PMID: 35662556 DOI: 10.1016/j.ijcard.2022.05.067] [Reference Citation Analysis]
15 Harada T, Kagami K, Kato T, Ishii H, Obokata M. Exercise Stress Echocardiography in the Diagnostic Evaluation of Heart Failure with Preserved Ejection Fraction. JCDD 2022;9:87. [DOI: 10.3390/jcdd9030087] [Reference Citation Analysis]
16 Bjerring AW, Fosså SD, Haugnes HS, Nome R, Stokke TM, Haugaa KH, Kiserud CE, Edvardsen T, Sarvari SI. The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up. Eur Heart J Cardiovasc Imaging 2021;22:443-50. [PMID: 33152065 DOI: 10.1093/ehjci/jeaa289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wenzel JP, Nikorowitsch J, Bei der Kellen R, Magnussen C, Bonin-Schnabel R, Westermann D, Twerenbold R, Kirchhof P, Blankenberg S, Schrage B. Heart failure in the general population and impact of the 2021 European Society of Cardiology Heart Failure Guidelines. ESC Heart Fail 2022. [PMID: 35445582 DOI: 10.1002/ehf2.13948] [Reference Citation Analysis]
18 Cicco S, Calvanese C, Susca N, Inglese G, Nardiello E, Ciampi S, Tedesco PA, Cirulli A, Panettieri I, Vacca A, Ranieri G. Right atrium enlargement is related to increased heart damage and mortality in well-controlled hypertension. Nutr Metab Cardiovasc Dis 2021:S0939-4753(21)00500-7. [PMID: 34893418 DOI: 10.1016/j.numecd.2021.10.004] [Reference Citation Analysis]
19 Jansen SMA, Huis In 't Veld AE, Jacobs W, Grotjohan HP, Waskowsky M, van der Maten J, van der Weerdt A, Hoekstra R, Overbeek MJ, Mollema SA, Tolen PHCG, Hassan El Bouazzaoui LH, Vriend JWJ, Roorda JMM, de Nooijer R, van der Lee I, Voogel BAJ, Peels K, Macken T, Aerts JM, Vonk Noordegraaf A, Handoko ML, de Man FS, Bogaard HJ. Noninvasive Prediction of Elevated Wedge Pressure in Pulmonary Hypertension Patients Without Clear Signs of Left-Sided Heart Disease: External Validation of the OPTICS Risk Score. J Am Heart Assoc 2020;9:e015992. [PMID: 32750312 DOI: 10.1161/JAHA.119.015992] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Ito H, Ishida M, Makino W, Goto Y, Ichikawa Y, Kitagawa K, Omori T, Dohi K, Ito M, Sakuma H. Cardiovascular magnetic resonance feature tracking for characterization of patients with heart failure with preserved ejection fraction: correlation of global longitudinal strain with invasive diastolic functional indices. J Cardiovasc Magn Reson 2020;22:42. [PMID: 32498688 DOI: 10.1186/s12968-020-00636-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
21 Ma CS, Liao YP, Fan JL, Zhao X, Su B, Zhou BY. The novel left atrial strain parameters in diagnosing of heart failure with preserved ejection fraction. Echocardiography 2022. [PMID: 35076951 DOI: 10.1111/echo.15304] [Reference Citation Analysis]
22 Ho JE, Redfield MM, Lewis GD, Paulus WJ, Lam CSP. Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction. Circulation 2020;142:1770-80. [PMID: 33136513 DOI: 10.1161/CIRCULATIONAHA.119.041818] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
23 Stengl H, Ganeshan R, Hellwig S, Blaszczyk E, Fiebach JB, Nolte CH, Bauer A, Schulz-Menger J, Endres M, Scheitz JF. Cardiomyocyte Injury Following Acute Ischemic Stroke: Protocol for a Prospective Observational Cohort Study. JMIR Res Protoc 2021;10:e24186. [PMID: 33544087 DOI: 10.2196/24186] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Alfuhied A, Kanagala P, McCann GP, Singh A. Multi-modality assessment and role of left atrial function as an imaging biomarker in cardiovascular disease. Int J Cardiovasc Imaging 2021. [PMID: 34169399 DOI: 10.1007/s10554-021-02316-x] [Reference Citation Analysis]
25 Soloveva A, Fedorova D, Villevalde S, Zvartau N, Mareev Y, Sitnikova M, Shlyakhto E, Fudim M. Addressing Orthostatic Hypotension in Heart Failure: Pathophysiology, Clinical Implications and Perspectives. J Cardiovasc Transl Res 2020;13:549-69. [PMID: 32748206 DOI: 10.1007/s12265-020-10044-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Sengeløv M, Biering-Sørensen T. Noninvasive Hemodynamic Evaluation at Rest in Heart Failure with Preserved Ejection Fraction. Heart Fail Clin 2021;17:423-34. [PMID: 34051974 DOI: 10.1016/j.hfc.2021.02.006] [Reference Citation Analysis]
27 Rieger AC, Bagno LL, Salerno A, Florea V, Rodriguez J, Rosado M, Turner D, Dulce RA, Takeuchi LM, Kanashiro-Takeuchi RM, Buchwald P, Wanschel ACBA, Balkan W, Schulman IH, Schally AV, Hare JM. Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction. Proc Natl Acad Sci U S A 2021;118:e2019835118. [PMID: 33468654 DOI: 10.1073/pnas.2019835118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Herrmann E, Huisl P, Aßmus B. [Novel European Heart Failure Guidelines - Change in Treatment Paradigms]. Dtsch Med Wochenschr 2022;147:326-31. [PMID: 35291038 DOI: 10.1055/a-1609-2469] [Reference Citation Analysis]
29 Chen J, Li M, Hao B, Cai Y, Li H, Zhou W, Song Y, Wang S, Liu H. Waist to height ratio is associated with an increased risk of mortality in Chinese patients with heart failure with preserved ejection fraction. BMC Cardiovasc Disord 2021;21:263. [PMID: 34049494 DOI: 10.1186/s12872-021-02080-9] [Reference Citation Analysis]
30 Myhre PL, Vaduganathan M, Greene SJ. Diagnosing heart failure with preserved ejection fraction in 2019: the search for a gold standard. Eur J Heart Fail 2020;22:422-4. [DOI: 10.1002/ejhf.1638] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Hagendorff A, Helfen A, Brandt R, Altiok E, Breithardt O, Haghi D, Knierim J, Lavall D, Merke N, Sinning C, Stöbe S, Tschöpe C, Knebel F, Ewen S. Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography. Clin Res Cardiol 2022. [PMID: 35660948 DOI: 10.1007/s00392-022-02041-y] [Reference Citation Analysis]
32 Abdellatif M, Patel J, Smits AM. Highlights of ESC Congress 2019: a report from the ESC Scientists of Tomorrow. Cardiovasc Res 2019;115:e151-4. [PMID: 31638159 DOI: 10.1093/cvr/cvz266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Backhaus SJ, Rösel SF, Schulz A, Lange T, Hellenkamp K, Gertz RJ, Wachter R, Steinmetz M, Kutty S, Raaz U, Friede T, Seidler T, Uecker M, Hasenfuß G, Schuster A. RT-CMR Imaging for Noninvasive Characterization of HFpEF: Medium-Term Outcomes of the HFpEF Stress Trial. JACC Cardiovasc Imaging 2022;15:943-5. [PMID: 35512961 DOI: 10.1016/j.jcmg.2021.11.013] [Reference Citation Analysis]
34 Gori M, D'Elia E, Iorio A, Iacovoni A, Senni M. Clinical application of personalized medicine: heart failure with preserved left ventricular ejection fraction. Eur Heart J Suppl 2020;22:L124-8. [PMID: 33239986 DOI: 10.1093/eurheartj/suaa151] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Li DM, Li BX, Yang LJ, Gao P, Ma ZY, Li ZJ Dr. Diagnostic value of circulating microRNA-208a in differentiation of preserved from reduced ejection fraction heart failure. Heart Lung 2021;50:71-4. [PMID: 32711895 DOI: 10.1016/j.hrtlng.2020.07.010] [Reference Citation Analysis]
36 Harada D, Asanoi H, Noto T, Takagawa J. The Impact of Deep Y Descent on Hemodynamics in Patients With Heart Failure and Preserved Left Ventricular Systolic Function. Front Cardiovasc Med 2021;8:770923. [PMID: 34926620 DOI: 10.3389/fcvm.2021.770923] [Reference Citation Analysis]
37 Tribolet de Abreu T. Heart failure with a preserved ejection fraction and the EMPEROR-Preserved Trial: a review of how we got here. Heart Fail Rev 2022. [PMID: 35604573 DOI: 10.1007/s10741-022-10244-8] [Reference Citation Analysis]
38 Morbach C, Wanner C, Störk S. [Update on diastolic heart failure]. Internist (Berl) 2022. [PMID: 35286435 DOI: 10.1007/s00108-022-01286-z] [Reference Citation Analysis]
39 Sun Y, Si J, Li J, Dai M, King E, Zhang X, Zhang Y, Xia Y, Tse G, Liu Y. Predictive Value of HFA-PEFF Score in Patients With Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2021;8:656536. [PMID: 34778384 DOI: 10.3389/fcvm.2021.656536] [Reference Citation Analysis]
40 Zhang X, Wang T, Chen Z, Wang H, Yin Y, Wang L, Wang Y, Xu B, Xu W. HMGB1‐Promoted Neutrophil Extracellular Traps Contribute to Cardiac Diastolic Dysfunction in Mice. JAHA. [DOI: 10.1161/jaha.121.023800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Nayor M, Xanthakis V, Tanguay M, Blodgett JB, Shah RV, Schoenike M, Sbarbaro J, Farrell R, Malhotra R, Houstis NE, Velagaleti RS, Moore SA, Baggish AL, O'Connor GT, Ho JE, Larson MG, Vasan RS, Lewis GD. Clinical and Hemodynamic Associations and Prognostic Implications of Ventilatory Efficiency in Patients With Preserved Left Ventricular Systolic Function. Circ Heart Fail 2020;13:e006729. [PMID: 32362167 DOI: 10.1161/CIRCHEARTFAILURE.119.006729] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
42 Weng SC, Chen YC, Hsu CY, Lin CS, Tarng DC, Lin SY. Impacts of Heart Failure and Physical Performance on Long-Term Mortality in Old Patients With Chronic Kidney Disease. Front Cardiovasc Med 2021;8:680098. [PMID: 34150871 DOI: 10.3389/fcvm.2021.680098] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Ritchie RH, Abel ED. Basic Mechanisms of Diabetic Heart Disease. Circ Res 2020;126:1501-25. [PMID: 32437308 DOI: 10.1161/CIRCRESAHA.120.315913] [Cited by in Crossref: 45] [Cited by in F6Publishing: 25] [Article Influence: 22.5] [Reference Citation Analysis]
44 Sorimachi H, Burkhoff D, Verbrugge FH, Omote K, Obokata M, Reddy YNV, Takahashi N, Sunagawa K, Borlaug BA. Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction. Eur J Heart Fail 2021. [PMID: 34053158 DOI: 10.1002/ejhf.2254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
45 Shah SJ, Borlaug BA, Kitzman DW, McCulloch AD, Blaxall BC, Agarwal R, Chirinos JA, Collins S, Deo RC, Gladwin MT, Granzier H, Hummel SL, Kass DA, Redfield MM, Sam F, Wang TJ, Desvigne-Nickens P, Adhikari BB. Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary. Circulation 2020;141:1001-26. [PMID: 32202936 DOI: 10.1161/CIRCULATIONAHA.119.041886] [Cited by in Crossref: 58] [Cited by in F6Publishing: 26] [Article Influence: 29.0] [Reference Citation Analysis]
46 Preda A, Liberale L, Montecucco F. Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome. Heart Fail Rev 2021. [PMID: 34796433 DOI: 10.1007/s10741-021-10195-6] [Reference Citation Analysis]
47 Pezel T, Hovasse T, Sanguineti F, Kinnel M, Garot P, Champagne S, Toupin S, Unterseeh T, Garot J. Long-Term Prognostic Value of Stress CMR in Patients With Heart Failure and Preserved Ejection Fraction. JACC Cardiovasc Imaging 2021;14:2319-33. [PMID: 34419409 DOI: 10.1016/j.jcmg.2021.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
48 Barbeito-Caamaño C, Bouzas-Mosquera A, Peteiro J, López-Vázquez D, Quintas-Guzmán M, Varela-Cancelo A, Martínez-Ruiz D, Yañez-Wonenburger JC, Piñeiro-Portela M, Vázquez-Rodríguez JM. Exercise testing in COVID-19 era: Clinical profile, results and feasibility wearing a facemask. Eur J Clin Invest 2021;51:e13509. [PMID: 33548060 DOI: 10.1111/eci.13509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Ewert R, Stubbe B, Heine A, Desole S, Habedank D, Knaack C, Hortien F, Opitz CF. [Invasive Cardiopulmonary Exercise Testing: A Review]. Pneumologie 2021. [PMID: 34844269 DOI: 10.1055/a-1651-7450] [Reference Citation Analysis]
50 Fermoyle CC, Stewart GM, Borlaug BA, Johnson BD. Pulmonary Vascular Pressures and Gas Exchange Response to Exercise in Heart Failure With Preserved Ejection Fraction. J Card Fail 2020;26:1011-5. [PMID: 32750488 DOI: 10.1016/j.cardfail.2020.07.009] [Reference Citation Analysis]
51 Nikorowitsch J, Bei der Kellen R, Kirchhof P, Magnussen C, Jagodzinski A, Schnabel RB, Blankenberg S, Wenzel JP. Applying the ESC 2016, H2 FPEF, and HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population. ESC Heart Fail 2021;8:3603-12. [PMID: 34459154 DOI: 10.1002/ehf2.13532] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Oakland H, Joseph P, Naeije R, Elassal A, Cullinan M, Heerdt PM, Singh I. Arterial load and right ventricular-vascular coupling in pulmonary hypertension. J Appl Physiol (1985) 2021;131:424-33. [PMID: 34043473 DOI: 10.1152/japplphysiol.00204.2021] [Reference Citation Analysis]
53 Arques S. Current clinical applications of spectral tissue Doppler echocardiography (E/e' ratio) as a noninvasive surrogate for left ventricular diastolic pressures in the diagnosis of heart failure with preserved ejection fraction. Revisited 15 years later. Ann Cardiol Angeiol (Paris) 2021:S0003-3928(21)00076-7. [PMID: 34130807 DOI: 10.1016/j.ancard.2021.05.010] [Reference Citation Analysis]
54 Zamfirescu MB, Ghilencea LN, Popescu MR, Bejan GC, Ghiordanescu IM, Popescu AC, Myerson SG, Dorobanțu M. A Practical Risk Score for Prediction of Early Readmission after a First Episode of Acute Heart Failure with Preserved Ejection Fraction. Diagnostics (Basel) 2021;11:198. [PMID: 33572844 DOI: 10.3390/diagnostics11020198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
55 Wintrich J, Abdin A, Böhm M. Management strategies in heart failure with preserved ejection fraction. Herz 2022. [PMID: 35524007 DOI: 10.1007/s00059-022-05119-5] [Reference Citation Analysis]
56 Briller JE, Mogos MF, Muchira JM, Piano MR. Pregnancy Associated Heart Failure With Preserved Ejection Fraction: Risk Factors and Maternal Morbidity. J Card Fail 2021;27:143-52. [PMID: 33388469 DOI: 10.1016/j.cardfail.2020.12.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
57 Chiribiri A, Masci PG. From the Epicardial Vessels to the Microcirculation: The Coronary Vasculature at the Crossroad of HFpEF. JACC Cardiovasc Imaging 2021;14:2334-6. [PMID: 34886995 DOI: 10.1016/j.jcmg.2021.09.019] [Reference Citation Analysis]
58 Šikić J, Planinić Z, Matišić V, Friščić T, Molnar V, Jagačić D, Vujičić L, Tudorić N, Postružin Gršić L, Ljubičić Đ, Primorac D. COVID-19: The Impact on Cardiovascular System. Biomedicines 2021;9:1691. [PMID: 34829920 DOI: 10.3390/biomedicines9111691] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Kim IC. Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction: Two Chronic Troublemakers. Heart Fail Clin 2021;17:377-86. [PMID: 34051970 DOI: 10.1016/j.hfc.2021.03.001] [Reference Citation Analysis]
60 S SK, Desai N, Gona OJ, K VK, B M. Impact of Updated 2016 ASE/EACVI VIS-À-VIS 2009 ASE Recommendation on the Prevalence of Diastolic Dysfunction and LV Filling Pressures in Patients with Preserved Ejection Fraction. J Cardiovasc Imaging 2021;29:31-43. [PMID: 33511798 DOI: 10.4250/jcvi.2020.0117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
61 Tadic M, Cuspidi C, Calicchio F, Grassi G, Mancia G. Diagnostic algorithm for HFpEF: how much is the recent consensus applicable in clinical practice? Heart Fail Rev 2020. [PMID: 32346825 DOI: 10.1007/s10741-020-09966-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Carpenito M, Fanti D, Mega S, Benfari G, Bono MC, Rossi A, Ribichini FL, Grigioni F. The Central Role of Left Atrium in Heart Failure. Front Cardiovasc Med 2021;8:704762. [PMID: 34485406 DOI: 10.3389/fcvm.2021.704762] [Reference Citation Analysis]
63 Salzano A, D'Assante R, Israr MZ, Eltayeb M, D'Agostino A, Bernieh D, De Luca M, Rega S, Ranieri B, Mauro C, Bossone E, Squire IB, Suzuki T, Marra AM. Biomarkers in Heart Failure: Clinical Insights. Heart Fail Clin 2021;17:223-43. [PMID: 33673947 DOI: 10.1016/j.hfc.2021.01.002] [Reference Citation Analysis]
64 Kilfoil PJ, Lotteau S, Zhang R, Yue X, Aynaszyan S, Solymani RE, Cingolani E, Marbán E, Goldhaber JI. Distinct features of calcium handling and β-adrenergic sensitivity in heart failure with preserved versus reduced ejection fraction. J Physiol 2020;598:5091-108. [PMID: 32829489 DOI: 10.1113/JP280425] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
65 Stewart Coats AJ. Validating the HFA-PEFF score - or how to define a disease? Eur J Heart Fail 2020;22:428-31. [PMID: 32100362 DOI: 10.1002/ejhf.1770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Nguyen ITN, Brandt MM, van de Wouw J, van Drie RWA, Wesseling M, Cramer MJ, de Jager SCA, Merkus D, Duncker DJ, Cheng C, Joles JA, Verhaar MC. Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction. PLoS One 2020;15:e0232399. [PMID: 32374790 DOI: 10.1371/journal.pone.0232399] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
67 Kobalava ZD, Safarova AF, Gudieva KM, Markova MA, Petrosyan AE. Comparative Efficacy of Single Pill Combinations of Azilsartan Medoxomil/Chlorthalidone and Losartan/Hydrochlorothiazide in Patients with Hypertension and Heart Failure with Preserved Ejection Fraction. Racionalʹnaâ farmakoterapiâ v kardiologii 2022;18:127-34. [DOI: 10.20996/1819-6446-2022-04-01] [Reference Citation Analysis]
68 Zhou G, Chen J, Wu C, Jiang P, Wang Y, Zhang Y, Jiang Y, Li X. Deciphering the Protein, Modular Connections and Precision Medicine for Heart Failure With Preserved Ejection Fraction and Hypertension Based on TMT Quantitative Proteomics and Molecular Docking. Front Physiol 2021;12:607089. [PMID: 34721049 DOI: 10.3389/fphys.2021.607089] [Reference Citation Analysis]
69 Sun W, Zou H, Yong Y, Liu B, Zhang H, Lu J, Shen Y, Li P, Xu T, Chen X, Du A, Jiang M, Hua Y, Sheng Y, Zhou B, Lotan C, Kong X. The RAISE Trial: A Novel Device and First-in-Man Trial. Circ Heart Fail 2022;15:e008362. [PMID: 35378984 DOI: 10.1161/CIRCHEARTFAILURE.121.008362] [Reference Citation Analysis]
70 Lüscher TF. Imaging the heart and the brain: from the amygdala to arterial inflammation. Eur Heart J 2020;41:727-30. [PMID: 33211802 DOI: 10.1093/eurheartj/ehaa102] [Reference Citation Analysis]
71 Guazzi M, Ghio S, Adir Y. Pulmonary Hypertension in HFpEF and HFrEF. Journal of the American College of Cardiology 2020;76:1102-11. [DOI: 10.1016/j.jacc.2020.06.069] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
72 Galli E, Bourg C, Kosmala W, Oger E, Donal E. Phenomapping Heart Failure with Preserved Ejection Fraction Using Machine Learning Cluster Analysis: Prognostic and Therapeutic Implications. Heart Fail Clin 2021;17:499-518. [PMID: 34051979 DOI: 10.1016/j.hfc.2021.02.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Simonovic D, Coiro S, Deljanin-Ilic M, Kobayashi M, Carluccio E, Girerd N, Ambrosio G. Exercise-induced B-lines in heart failure with preserved ejection fraction occur along with diastolic function worsening. ESC Heart Fail 2021. [PMID: 34655174 DOI: 10.1002/ehf2.13575] [Reference Citation Analysis]
74 Sotomi Y, Hikoso S, Nakatani D, Mizuno H, Okada K, Dohi T, Kitamura T, Sunaga A, Kida H, Oeun B, Sato T, Komukai S, Tamaki S, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Yasumura Y, Yamada T, Sakata Y; PURSUIT‐HFpEF Investigators. Sex Differences in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc 2021;10:e018574. [PMID: 33619973 DOI: 10.1161/JAHA.120.018574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
75 Schauer A, Draskowski R, Jannasch A, Kirchhoff V, Goto K, Männel A, Barthel P, Augstein A, Winzer E, Tugtekin M, Labeit S, Linke A, Adams V. ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction. ESC Heart Fail 2020;7:2123-34. [PMID: 32710530 DOI: 10.1002/ehf2.12915] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
76 Park JJ. Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes. Diabetes Metab J 2021;45:146-57. [PMID: 33813813 DOI: 10.4093/dmj.2020.0282] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Wang M, Shan Y, Wu C, Cao P, Sun W, Han J, Shen L, Chen J, Yu P, Chen X. Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. Front Pharmacol 2020;11:626375. [PMID: 33633570 DOI: 10.3389/fphar.2020.626375] [Reference Citation Analysis]
78 Bayes-Genis A, Pascual-Figal D, Núñez J. The pre-HFpEF stage: a new entity that requires proper phenotyping for better management. Eur J Prev Cardiol 2020;:2047487320902326. [PMID: 32019372 DOI: 10.1177/2047487320902326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Burgdorf C, Brockmöller J, Strampe H, Januszewski M, Remppis BA. Reduction of Pulmonary Hypertension After Transition to Sacubitril/Valsartan in Patients With Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2021;8:734697. [PMID: 34692786 DOI: 10.3389/fcvm.2021.734697] [Reference Citation Analysis]
80 Tromp J, Claggett BL, Liu J, Jackson AM, Jhund PS, Køber L, Widimský J, Boytsov SA, Chopra VK, Anand IS, Ge J, Chen CH, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, Rizkala AR, Inubushi-Molessa A, Lefkowitz MP, Shi VC, McMurray JJV, Solomon SD, Lam CSP; PARAGON-HF Investigators. Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial. Circ Heart Fail 2021;14:e007901. [PMID: 33866828 DOI: 10.1161/CIRCHEARTFAILURE.120.007901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Pastori D, Ames PRJ, Triggiani M, Ciampa A, Cammisotto V, Carnevale R, Pignatelli P, Bucci T, On Behalf Of The Athero-Aps Study Group. Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study. J Clin Med 2021;10:3180. [PMID: 34300346 DOI: 10.3390/jcm10143180] [Reference Citation Analysis]
82 Keramida K, Maniotis C, Makavos G, Papadopoulos CH, Stefanidis A, Georgilas AT, Beldekos DJ, Kouris N, Aggeli C, Anastasiadis G, Bonou M, Bountioukos M, Chamodraka E, Chrissos DN, Christodoulides T, Dermitzakis G, Evdoridis C, Fotiadis J, Foukarakis E, Frogoudaki AA, Garidas G, Grassos C, Ikonomidis I, Ioannides M, Ionitsa S, Kadoglou N, Kafarakis P, Kaipis D, Kairis C, Kamperidis V, Karabinos I, Karagiannis S, Karali K, Katranis AG, Ketikoglou D, Klettas D, Kokladi M, Komporozos C, Kostaki PG, Kostopoulos V, Kounas S, Koutroulis G, Kypris L, Kyrzopoulos S, Masoura C, Mavrommatis P, Meidanis K, Michailidis N, Mytas D, Pappas K, Krommydas A, Loukidelis G, Matthaios I, Nikitas GT, Papadopoulos A, Papandreou A, Patrianakos A, Patsouras D, Petropoulou E, Polymeros S, Rallidis LS, Sachpekidis V, Savvalas D, Sihlimiris I, Stergiou A, Tsiapras D, Tsougkos E, Tsoukas A, Tzortzis S, Vachliotis V, Vrettou A, Yiangou K, Zaglavara T. Stress echocardiography: differences between practices in Greece. A survey of the Echocardiology Working Group of the Hellenic Society of Cardiology. Hellenic Journal of Cardiology 2021;62:221-4. [DOI: 10.1016/j.hjc.2020.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Pieske B, Morris DA. History of acute coronary syndrome: a common, maybe underestimated, risk factor for heart failure with preserved ejection fraction. Rev Esp Cardiol (Engl Ed) 2021;74:480-1. [PMID: 33455892 DOI: 10.1016/j.rec.2020.12.007] [Reference Citation Analysis]
84 Tadic M, Cuspidi C. Hypertension, diastolic stress test, and HFpEF: Does new scoring system change something? J Clin Hypertens (Greenwich) 2019;21:1905-7. [PMID: 31769582 DOI: 10.1111/jch.13743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
85 Shim CY. Stress Testing in Heart Failure with Preserved Ejection Fraction. Heart Fail Clin 2021;17:435-45. [PMID: 34051975 DOI: 10.1016/j.hfc.2021.02.007] [Reference Citation Analysis]
86 Bandera F, Barletta M, Fontana M, Boveri S, Ghizzardi G, Alfonzetti E, Ambrogi F, Guazzi M. Exercise-induced mitral regurgitation and right ventricle to pulmonary circulation uncoupling across the heart failure phenotypes. Am J Physiol Heart Circ Physiol 2021;320:H642-53. [PMID: 33306448 DOI: 10.1152/ajpheart.00507.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Vriz O, Palatini P, Rudski L, Frumento P, Kasprzak JD, Ferrara F, Cocchia R, Gargani L, Wierzbowska-drabik K, Capone V, Ranieri B, Salzano A, Stanziola AA, Marra AM, Annunziata R, Chianese S, Rega S, Saltalamacchia T, Maramaldi R, Sepe C, Limongelli G, Cademartiri F, D’andrea A, D’alto M, Izzo R, Ferrara N, Mauro C, Cittadini A, Ekkehard G, Guazzi M, Bossone E. Right Heart Pulmonary Circulation Unit Response to Exercise in Patients with Controlled Systemic Arterial Hypertension: Insights from the RIGHT Heart International NETwork (RIGHT-NET). JCM 2022;11:451. [DOI: 10.3390/jcm11020451] [Reference Citation Analysis]
88 Chuda A, Banach M, Maciejewski M, Bielecka-Dabrowa A. Role of confirmed and potential predictors of an unfavorable outcome in heart failure in everyday clinical practice. Ir J Med Sci 2021. [PMID: 33595788 DOI: 10.1007/s11845-020-02477-z] [Reference Citation Analysis]
89 Dzhioeva O, Belyavskiy E. Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations. Ther Clin Risk Manag 2020;16:769-85. [PMID: 32904123 DOI: 10.2147/TCRM.S207117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Tourki B, Kain V, Shaikh SR, Leroy X, Serhan CN, Halade GV. Deficit of resolution receptor magnifies inflammatory leukocyte directed cardiorenal and endothelial dysfunction with signs of cardiomyopathy of obesity. FASEB J 2020;34:10560-73. [PMID: 32543720 DOI: 10.1096/fj.202000495RR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
91 Zhou D, Yan M, Cheng Q, Feng X, Tang S, Feng Y. Prevalence and prognosis of left ventricular diastolic dysfunction in community hypertension patients. BMC Cardiovasc Disord 2022;22:265. [PMID: 35698035 DOI: 10.1186/s12872-022-02709-3] [Reference Citation Analysis]
92 Fayol A, Livrozet M, Boutouyrie P, Khettab H, Betton M, Tea V, Blanchard A, Bruno RM, Hulot JS; French COVID cohort study group. Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study. ESC Heart Fail 2021;8:2232-9. [PMID: 33773099 DOI: 10.1002/ehf2.13315] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
93 Nanayakkara S, Kaye DM. Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction. Heart Fail Rev 2022. [PMID: 35438418 DOI: 10.1007/s10741-022-10236-8] [Reference Citation Analysis]
94 Cleland JGF, Pfeffer MA, Clark AL, Januzzi JL, McMurray JJV, Mueller C, Pellicori P, Richards M, Teerlink JR, Zannad F, Bauersachs J. The struggle towards a Universal Definition of Heart Failure-how to proceed? Eur Heart J 2021;42:2331-43. [PMID: 33791787 DOI: 10.1093/eurheartj/ehab082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
95 Vaishnav J, Sharma K. A Stepwise Guide to the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction. J Card Fail 2021:S1071-9164(21)00525-X. [PMID: 34968656 DOI: 10.1016/j.cardfail.2021.12.013] [Reference Citation Analysis]
96 Manouras A, Johnson J, Lund LH, Nagy AI. Optimizing diastolic pressure gradient assessment. Clin Res Cardiol 2020;109:1411-22. [PMID: 32394159 DOI: 10.1007/s00392-020-01641-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Carballo D, Garin N, Stirnemann J, Mamin A, Prendki V, Meyer P, Marti C, Mach F, Reny JL, Serratrice J, Kaiser L, Carballo S. Prognosis of Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in Acute Heart Failure. J Clin Med 2021;10:4546. [PMID: 34640562 DOI: 10.3390/jcm10194546] [Reference Citation Analysis]
98 Abdellatif M, Trummer-Herbst V, Koser F, Durand S, Adão R, Vasques-Nóvoa F, Freundt JK, Voglhuber J, Pricolo MR, Kasa M, Türk C, Aprahamian F, Herrero-Galán E, Hofer SJ, Pendl T, Rech L, Kargl J, Anto-Michel N, Ljubojevic-Holzer S, Schipke J, Brandenberger C, Auer M, Schreiber R, Koyani CN, Heinemann A, Zirlik A, Schmidt A, von Lewinski D, Scherr D, Rainer PP, von Maltzahn J, Mühlfeld C, Krüger M, Frank S, Madeo F, Eisenberg T, Prokesch A, Leite-Moreira AF, Lourenço AP, Alegre-Cebollada J, Kiechl S, Linke WA, Kroemer G, Sedej S. Nicotinamide for the treatment of heart failure with preserved ejection fraction. Sci Transl Med 2021;13:eabd7064. [PMID: 33568522 DOI: 10.1126/scitranslmed.abd7064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
99 Schick BM, Dlugas H, Czeiszperger TL, Matus AR, Bukowski MJ, Chung CS. Reduced preload increases Mechanical Control (strain-rate dependence) of Relaxation by modifying myosin kinetics. Arch Biochem Biophys 2021;707:108909. [PMID: 34015323 DOI: 10.1016/j.abb.2021.108909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Bauersachs J, de Boer RA, Lindenfeld J, Bozkurt B. The year in cardiovascular medicine 2021: heart failure and cardiomyopathies. Eur Heart J 2022:ehab887. [PMID: 34974611 DOI: 10.1093/eurheartj/ehab887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 von Roeder M, Blazek S, Rommel KP, Kresoja KP, Gioia G, Mentzel L, Lurz JA, Besler C, Fengler K, Hindricks G, Desch S, Thiele H, Lurz P. Changes in left atrial function in patients undergoing cardioversion for atrial fibrillation: relevance of left atrial strain in heart failure. Clin Res Cardiol 2021. [PMID: 34932171 DOI: 10.1007/s00392-021-01982-0] [Reference Citation Analysis]
102 Kleefeld F, Scherret E, Knebel F, Messroghli D, Heidecker B, Wetz C, Schatka I, Barzen G, Tschöpe C, Amthauer H, Hahn K. Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis. Amyloid 2022;:1-10. [PMID: 34994254 DOI: 10.1080/13506129.2021.2014448] [Reference Citation Analysis]
103 Hauser T, Dornberger V, Malzahn U, Grebe SJ, Liu D, Störk S, Nauck M, Friedrich N, Dörr M, Wanner C, Krane V, Hammer F; MiREnDa Study Group., Collaborating investigators (sites). The effect of spironolactone on diastolic function in haemodialysis patients. Int J Cardiovasc Imaging 2021;37:1927-36. [PMID: 33544240 DOI: 10.1007/s10554-021-02176-5] [Reference Citation Analysis]
104 Egashira K, Sueta D, Komorita T, Yamamoto E, Usuku H, Tokitsu T, Fujisue K, Nishihara T, Oike F, Takae M, Hanatani S, Takashio S, Ito M, Yamanaga K, Araki S, Soejima H, Kaikita K, Matsushita K, Tsujita K. HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction. Korean J Intern Med 2021. [PMID: 34929994 DOI: 10.3904/kjim.2021.272] [Reference Citation Analysis]
105 Tian L, Duan F, Li X, Zhou C. Incidence, risk factors and prognostic effect of imaging left ventricular diastolic dysfunction in patients with COVID-19: protocol for a systematic review. BMJ Open 2022;12:e059281. [PMID: 35477881 DOI: 10.1136/bmjopen-2021-059281] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Karaliute R, Jureviciute J, Jurgaityte J, Rimkute A, Mizariene V, Baksyte G, Kazakevicius T, Urboniene D, Kavoliuniene A. The Predictive Value of Tissue Doppler Indices for Early Recurrence of Atrial Fibrillation After Electrical Cardioversion. Clin Interv Aging 2020;15:1917-25. [PMID: 33116446 DOI: 10.2147/CIA.S263303] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-726. [PMID: 34447992 DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 209] [Cited by in F6Publishing: 73] [Article Influence: 209.0] [Reference Citation Analysis]
108 Yoo J, Grewal P, Hotelling J, Papamanoli A, Cao K, Dhaliwal S, Jacob R, Mojahedi A, Bloom ME, Marcos LA, Skopicki HA, Kalogeropoulos AP. Admission NT-proBNP and outcomes in patients without history of heart failure hospitalized with COVID-19. ESC Heart Fail 2021. [PMID: 34346182 DOI: 10.1002/ehf2.13548] [Reference Citation Analysis]
109 Pagel PS, Tawil JN, Boettcher BT, Izquierdo DA, Lazicki TJ, Crystal GJ, Freed JK. Heart Failure With Preserved Ejection Fraction: A Comprehensive Review and Update of Diagnosis, Pathophysiology, Treatment, and Perioperative Implications. J Cardiothorac Vasc Anesth 2021;35:1839-59. [PMID: 32747202 DOI: 10.1053/j.jvca.2020.07.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
110 Myhre PL, Selvaraj S, Solomon SD. Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal? Curr Opin Cardiol 2021;36:413-9. [PMID: 33709982 DOI: 10.1097/HCO.0000000000000852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Abramov D, Parwani P. Diving Into the Diagnostic Score Algorithms of Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2021;8:665424. [PMID: 34179132 DOI: 10.3389/fcvm.2021.665424] [Reference Citation Analysis]
112 Zamfirescu MB, Ghilencea LN, Popescu MR, Bejan GC, Maher SM, Popescu AC, Dorobanțu M. The E/e' Ratio-Role in Risk Stratification of Acute Heart Failure with Preserved Ejection Fraction. Medicina (Kaunas) 2021;57:375. [PMID: 33924367 DOI: 10.3390/medicina57040375] [Reference Citation Analysis]
113 Lin Y, Fu S, Yao Y, Li Y, Zhao Y, Luo L. Heart failure with preserved ejection fraction based on aging and comorbidities. J Transl Med 2021;19:291. [PMID: 34229717 DOI: 10.1186/s12967-021-02935-x] [Reference Citation Analysis]
114 Rattka M, Kühberger A, Pott A, Stephan T, Weinmann K, Baumhardt M, Aktolga D, Teumer Y, Bothner C, Scharnbeck D, Rottbauer W, Dahme T. Catheter ablation for atrial fibrillation in HFpEF patients-A propensity-score-matched analysis. J Cardiovasc Electrophysiol 2021. [PMID: 34379370 DOI: 10.1111/jce.15200] [Reference Citation Analysis]
115 Baratto C, Caravita S, Soranna D, Dewachter C, Bondue A, Zambon A, Badano LP, Parati G, Vachiéry JL. Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta-analysis. ESC Heart Fail 2022. [PMID: 35748109 DOI: 10.1002/ehf2.13979] [Reference Citation Analysis]
116 Tereshchenko SN, Zhirov IV, Uskach TM, Saidova MA, Golitsyn SP, Gupalo EM, Nasonova SN, Narusov OY, Safiullina AA, Tereshchenko AS, Stukalova OV. EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020). Evrazijskij kardiologičeskij žurnal 2020. [DOI: 10.38109/2225-1685-2020-3-6-76] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Ianoș RD, Pop C, Iancu M, Rahaian R, Cozma A, Procopciuc LM. Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus. Diagnostics (Basel) 2021;11:1577. [PMID: 34573919 DOI: 10.3390/diagnostics11091577] [Reference Citation Analysis]
118 Seferović PM, Vardas P, Jankowska EA, Maggioni AP, Timmis A, Milinković I, Polovina M, Gale CP, Lund LH, Lopatin Y, Lainscak M, Savarese G, Huculeci R, Kazakiewicz D, Coats AJS; National Heart Failure Societies of the ESC member countries (see Appendix). The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019. Eur J Heart Fail 2021. [PMID: 33634931 DOI: 10.1002/ejhf.2143] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
119 Ye Z, Miranda WR, Yeung DF, Kane GC, Oh JK. Left Atrial Strain in Evaluation of Heart Failure with Preserved Ejection Fraction. J Am Soc Echocardiogr 2020;33:1490-9. [PMID: 32981787 DOI: 10.1016/j.echo.2020.07.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
120 Smeets M, Vaes B, Aertgeerts B, Raat W, Penders J, Vercammen J, Droogne W, Mullens W, Janssens S. Impact of an extended audit on identifying heart failure patients in general practice: baseline results of the OSCAR-HF pilot study. ESC Heart Fail 2020. [PMID: 32969599 DOI: 10.1002/ehf2.12990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; Authors/Task Force Members:., ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4-131. [PMID: 35083827 DOI: 10.1002/ejhf.2333] [Cited by in Crossref: 92] [Cited by in F6Publishing: 22] [Article Influence: 92.0] [Reference Citation Analysis]
122 Wierzbowska-Drabik K, Kasprzak JD, Haberka M, Peteiro J, Re F, D'Alfonso MG, Mori F, Palinkas ED, Agoston G, Varga A, Djordjevic-Dikic A, Tesic M, Zagatina A, Rodriguez-Zanella H, Simova I, Merli E, Morrone D, D'Andrea A, Camarozano AC, Reisenhofer B, Prota C, Citro R, Celutkiene J, Boshchenko A, Ciampi Q, Picano E. Left atrial volume changes during exercise stress echocardiography in heart failure and hypertrophic cardiomyopathy: Exercise echocardiography and left atrial changes. Hellenic J Cardiol 2022:S1109-9666(22)00018-5. [PMID: 35123008 DOI: 10.1016/j.hjc.2022.01.003] [Reference Citation Analysis]
123 Flachskampf F, Baron T. Heart failure and cardiac imaging: Choosing wisely in the era of multimodality imaging. Anatol J Cardiol 2020;23:204-8. [PMID: 32235137 DOI: 10.14744/AnatolJCardiol.2020.66745] [Reference Citation Analysis]
124 Sopek Merkaš I, Slišković AM, Lakušić N. Current concept in the diagnosis, treatment and rehabilitation of patients with congestive heart failure. World J Cardiol 2021; 13(7): 183-203 [PMID: 34367503 DOI: 10.4330/wjc.v13.i7.183] [Reference Citation Analysis]
125 Chen H, Chhor M, Rayner BS, McGrath K, McClements L. Evaluation of the diagnostic accuracy of current biomarkers in heart failure with preserved ejection fraction: A systematic review and meta-analysis. Arch Cardiovasc Dis 2021;114:793-804. [PMID: 34802963 DOI: 10.1016/j.acvd.2021.10.007] [Reference Citation Analysis]
126 Wintrich J, Kindermann I, Ukena C, Selejan S, Werner C, Maack C, Laufs U, Tschöpe C, Anker SD, Lam CSP, Voors AA, Böhm M. Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future. Clin Res Cardiol 2020;109:1079-98. [PMID: 32236720 DOI: 10.1007/s00392-020-01633-w] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 14.5] [Reference Citation Analysis]
127 Pellicori P, Platz E, Dauw J, Ter Maaten JM, Martens P, Pivetta E, Cleland JGF, McMurray JJV, Mullens W, Solomon SD, Zannad F, Gargani L, Girerd N. Ultrasound imaging of congestion in heart failure: examinations beyond the heart. Eur J Heart Fail 2021;23:703-12. [PMID: 33118672 DOI: 10.1002/ejhf.2032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
128 Fermoyle CC, Stewart GM, Borlaug BA, Johnson BD. Simultaneous Measurement of Lung Diffusing Capacity and Pulmonary Hemodynamics Reveals Exertional Alveolar-Capillary Dysfunction in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc 2021;10:e019950. [PMID: 34369164 DOI: 10.1161/JAHA.120.019950] [Reference Citation Analysis]
129 Duca F, Snidat A, Binder C, Rettl R, Dachs TM, Seirer B, Camuz-Ligios L, Dusik F, Capelle CDJ, Hong Q, Agis H, Kain R, Mascherbauer J, Hengstenberg C, Badr Eslam R, Bonderman D. Hemodynamic Profiles and Their Prognostic Relevance in Cardiac Amyloidosis. J Clin Med 2020;9:E1093. [PMID: 32290508 DOI: 10.3390/jcm9041093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Penso M, Solbiati S, Moccia S, Caiani EG. Decision Support Systems in HF based on Deep Learning Technologies. Curr Heart Fail Rep 2022. [PMID: 35142985 DOI: 10.1007/s11897-022-00540-7] [Reference Citation Analysis]
131 Harada T, Kagami K, Kato T, Obokata M. Echocardiography in the diagnostic evaluation and phenotyping of heart failure with preserved ejection fraction. J Cardiol 2021:S0914-5087(21)00313-0. [PMID: 34857430 DOI: 10.1016/j.jjcc.2021.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
132 Koutroumpakis E, Kaur R, Taegtmeyer H, Deswal A. Obesity and Heart Failure with Preserved Ejection Fraction. Heart Fail Clin 2021;17:345-56. [PMID: 34051967 DOI: 10.1016/j.hfc.2021.02.003] [Reference Citation Analysis]
133 Fayol A, Wack M, Livrozet M, Carves JB, Domengé O, Vermersch E, Mirabel M, Karras A, Le Guen J, Blanchard A, Azizi M, Amar L, Bories MC, Mousseaux E, Carette C, Puymirat E, Hagège A, Jannot AS, Hulot JS. Aetiological classification and prognosis in patients with heart failure with preserved ejection fraction. ESC Heart Fail 2021. [PMID: 34841727 DOI: 10.1002/ehf2.13717] [Reference Citation Analysis]
134 He J, Yang W, Wu W, Li S, Yin G, Zhuang B, Xu J, Sun X, Zhou D, Wei B, Sirajuddin A, Teng Z, Zhao S, Kureshi F, Lu M. Early Diastolic Longitudinal Strain Rate at MRI and Outcomes in Heart Failure with Preserved Ejection Fraction. Radiology 2021;301:582-92. [PMID: 34519577 DOI: 10.1148/radiol.2021210188] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Selvaraj S, Myhre PL, Vaduganathan M, Claggett BL, Matsushita K, Kitzman DW, Borlaug BA, Shah AM, Solomon SD. Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community. JACC Heart Fail 2020;8:640-53. [PMID: 32535127 DOI: 10.1016/j.jchf.2020.03.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
136 Akhtar AM, Ghouri N, Chahal CAA, Patel R, Ricci F, Sattar N, Waqar S, Khanji MY. Ramadan fasting: recommendations for patients with cardiovascular disease. Heart 2021:heartjnl-2021-319273. [PMID: 33990414 DOI: 10.1136/heartjnl-2021-319273] [Reference Citation Analysis]
137 Toth PP, Gauthier D. Heart failure with preserved ejection fraction: strategies for disease management and emerging therapeutic approaches. Postgrad Med 2021;133:125-39. [PMID: 33283589 DOI: 10.1080/00325481.2020.1842620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
138 Kasiakogias A, Rosei EA, Camafort M, Ehret G, Faconti L, Ferreira JP, Brguljan J, Januszewicz A, Kahan T, Manolis A, Tsioufis K, Weber T, von Lueder TG, Smiseth OA, Wachtell K, Kjeldsen SE, Zannad F, Mancia G, Kreutz R. Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension. J Hypertens 2021;39:1522-45. [PMID: 34102660 DOI: 10.1097/HJH.0000000000002910] [Reference Citation Analysis]
139 Anker SD, Khan MS, Shahid I, Filippatos G, Coats AJS, Butler J. Sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: reasons for optimism. Eur J Heart Fail 2021;23:1250-5. [PMID: 34173305 DOI: 10.1002/ejhf.2279] [Reference Citation Analysis]
140 Farmakis D, Chrysohoou C, Giamouzis G, Giannakoulas G, Hamilos M, Naka K, Tzeis S, Xydonas S, Karavidas A, Parissis J. The management of atrial fibrillation in heart failure: an expert panel consensus. Heart Fail Rev 2020. [PMID: 32468277 DOI: 10.1007/s10741-020-09978-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
141 Ho JE, Nguyen C, Lewis GD. Unmasking Nonpreserved Heart Structure, Function, and Energetics in Heart Failure With Preserved Ejection Fraction With Magnetic Resonance Imaging Coupled With Exercise. Circulation 2021;144:1679-82. [PMID: 34743526 DOI: 10.1161/CIRCULATIONAHA.121.056974] [Reference Citation Analysis]
142 Liu C, Feng YP, Yan ZN, Fan L, Rui YF, Cui L. Value of quantitative analysis of left ventricular systolic function in patients on maintenance hemodialysis based on myocardial work technique. BMC Cardiovasc Disord 2021;21:76. [PMID: 33549050 DOI: 10.1186/s12872-021-01899-6] [Reference Citation Analysis]
143 Faxen UL, Venkateshvaran A, Shah SJ, Lam CSP, Svedlund S, Saraste A, Beussink-Nelson L, Lagerstrom Fermer M, Gan LM, Hage C, Lund LH. Generalizability of HFA-PEFF and H2FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF. J Card Fail 2021;27:756-65. [PMID: 33647474 DOI: 10.1016/j.cardfail.2021.02.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
144 Teschke R, Danan G. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM). Diagnostics (Basel) 2021;11:458. [PMID: 33800917 DOI: 10.3390/diagnostics11030458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
145 Halliday BP, Senior R, Pennell DJ. Assessing left ventricular systolic function: from ejection fraction to strain analysis. Eur Heart J 2021;42:789-97. [PMID: 32974648 DOI: 10.1093/eurheartj/ehaa587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
146 Hsu S, Fang JC, Borlaug BA. Hemodynamics for the Heart Failure Clinician: A State-of-the-Art Review. J Card Fail 2021:S1071-9164(21)00306-7. [PMID: 34389460 DOI: 10.1016/j.cardfail.2021.07.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
147 Toledo C, Ortolani D, Ortiz FC, Marcus NJ, Del Rio R. Potential Role of the Retrotrapezoid Nucleus in Mediating Cardio-Respiratory Dysfunction in Heart Failure With Preserved Ejection Fraction. Front Physiol 2022;13:863963. [DOI: 10.3389/fphys.2022.863963] [Reference Citation Analysis]
148 He J, Yang W, Jiang Y, Sun X, Zhao S, Weiss R, Sirajuddin A, Lu M. Heart failure with preserved ejection fraction assessed by cardiac magnetic resonance: From clinical uses to emerging techniques. Trends Cardiovasc Med 2021:S1050-1738(21)00156-0. [PMID: 34933114 DOI: 10.1016/j.tcm.2021.12.006] [Reference Citation Analysis]
149 Gupta AN, Markl M, Elbaz MSM. Intracardiac and Vascular Hemodynamics with Cardiovascular Magnetic Resonance in Heart Failure. Heart Fail Clin 2021;17:135-47. [PMID: 33220882 DOI: 10.1016/j.hfc.2020.08.010] [Reference Citation Analysis]
150 Lüscher TF. Challenges in atrial fibrillation: detection, alert systems, fibrosis, and infection. Eur Heart J 2020;41:1063-6. [PMID: 33216858 DOI: 10.1093/eurheartj/ehaa153] [Reference Citation Analysis]
151 Lévy S, Steinbeck G, Santini L, Nabauer M, Maceda DP, Kantharia BK, Saksena S, Cappato R. Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society. J Interv Card Electrophysiol 2022. [PMID: 35419669 DOI: 10.1007/s10840-022-01195-z] [Reference Citation Analysis]
152 Berezin AE, Berezin AA. Point-of-care heart failure platform: where are we now and where are we going to? Expert Rev Cardiovasc Ther 2022. [PMID: 35588730 DOI: 10.1080/14779072.2022.2080657] [Reference Citation Analysis]
153 Braunwald E. Heart failure with preserved ejection fraction: a stepchild no more! Eur Heart J 2021;42:3900-1. [PMID: 34619759 DOI: 10.1093/eurheartj/ehab601] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
154 Verbrugge FH, Reddy YNV, Sorimachi H, Omote K, Carter RE, Borlaug BA. Diagnostic scores predict morbidity and mortality in patients hospitalized for heart failure with preserved ejection fraction. Eur J Heart Fail 2021;23:954-63. [PMID: 33634544 DOI: 10.1002/ejhf.2142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
155 Todd N, Lai YC. Current Understanding of Circulating Biomarkers in Pulmonary Hypertension Due to Left Heart Disease. Front Med (Lausanne) 2020;7:570016. [PMID: 33117832 DOI: 10.3389/fmed.2020.570016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Kim MN, Park SM. Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction. Heart Fail Clin 2021;17:463-82. [PMID: 34051977 DOI: 10.1016/j.hfc.2021.02.008] [Reference Citation Analysis]
157 Ouwerkerk W, Tromp J, Jin X, Jaufeerally F, Yeo PSD, Leong KTG, Ong HY, Ling LH, Loh SY, Sim D, Lee S, Soon D, Chin C, Richards AM, Lam CS. Heart failure with preserved ejection fraction diagnostic scores in an Asian population. Eur J Heart Fail 2020;22:1737-9. [DOI: 10.1002/ejhf.1851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
158 Martens P, Herbots L, Timmermans P, Verbrugge FH, Dendale P, Borlaug BA, Verwerft J. Cardiopulmonary Exercise Testing with Echocardiography to Identify Mechanisms of Unexplained Dyspnea. J Cardiovasc Transl Res 2021. [PMID: 34110608 DOI: 10.1007/s12265-021-10142-8] [Reference Citation Analysis]
159 Ma H, Su Z, Yang Z, Li Y, Yang X, Zhao D, Chen X, Pallikonda Rajasekaran M. Renal Dynamic Imaging Information Data in the Evaluation of Renal Function in Patients with Chronic Heart Failure under the Guidance of Intelligent Region of Interest Detection Algorithm. Scientific Programming 2022;2022:1-8. [DOI: 10.1155/2022/5842231] [Reference Citation Analysis]
160 MacNamara JP, Sarma S. Faltering Under Pressure: Limitations to Noninvasive Diastolic Function Assessments. J Am Heart Assoc 2021;10:e023189. [PMID: 34476981 DOI: 10.1161/JAHA.121.023189] [Reference Citation Analysis]
161 Kobediona M, Bartunek J, Delrue L, Van Durme F, Lau CW, Moya A, Verstreken S, Heggermont W, Dierckx R, Goethals M, Vanderheyden M. Hemodynamic Response to Acute Volume Load and Endomyocardial NO-synthase Gene Expression in Heart Transplant Recipients. Transplantation Direct 2022;8:e1336. [DOI: 10.1097/txd.0000000000001336] [Reference Citation Analysis]
162 Obokata M, Reddy YNV, Melenovsky V, Sorimachi H, Jarolim P, Borlaug BA. Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity. Eur J Heart Fail 2021. [PMID: 34755429 DOI: 10.1002/ejhf.2377] [Reference Citation Analysis]
163 Zhou Y, Zhao CM, Shen ZY, Zhao X, Zhou BY. Mitral early-diastolic inflow peak velocity (E)-to-left atrial strain ratio as a novel index for predicting elevated left ventricular filling pressures in patients with preserved left ventricular ejection fraction. Cardiovasc Ultrasound 2021;19:17. [PMID: 33894780 DOI: 10.1186/s12947-021-00248-z] [Reference Citation Analysis]
164 Blum M, Hashemi D, Motzkus LA, Neye M, Dordevic A, Zieschang V, Zamani SM, Lapinskas T, Runte K, Kelm M, Kühne T, Tahirovic E, Edelmann F, Pieske B, Düngen HD, Kelle S. Variability of Myocardial Strain During Isometric Exercise in Subjects With and Without Heart Failure. Front Cardiovasc Med 2020;7:111. [PMID: 32714945 DOI: 10.3389/fcvm.2020.00111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Task Force for the management of COVID-19 of the European Society of Cardiology . European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Eur Heart J 2021:ehab696. [PMID: 34791157 DOI: 10.1093/eurheartj/ehab696] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
166 Tanasa A, Tapoi L, Ureche C, Sascau R, Statescu C, Covic A. Left atrial strain: A novel "biomarker" for chronic kidney disease patients? Echocardiography 2021;38:2077-82. [PMID: 34820890 DOI: 10.1111/echo.15259] [Reference Citation Analysis]
167 Trauzeddel RF, Ertmer M, Nordine M, Groesdonk HV, Michels G, Pfister R, Reuter D, Scheeren TWL, Berger C, Treskatsch S. Perioperative echocardiography-guided hemodynamic therapy in high-risk patients: a practical expert approach of hemodynamically focused echocardiography. J Clin Monit Comput 2021;35:229-43. [PMID: 32458170 DOI: 10.1007/s10877-020-00534-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Cuijpers I, Simmonds SJ, van Bilsen M, Czarnowska E, González Miqueo A, Heymans S, Kuhn AR, Mulder P, Ratajska A, Jones EAV, Brakenhielm E. Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities. Basic Res Cardiol 2020;115:39. [PMID: 32451732 DOI: 10.1007/s00395-020-0798-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
169 Hagendorff A, Stöbe S, Kandels J, de Boer R, Tschöpe C. Diagnostic role of echocardiography for patients with heart failure symptoms and preserved left ventricular ejection fraction. Herz 2022. [PMID: 35499562 DOI: 10.1007/s00059-022-05118-6] [Reference Citation Analysis]
170 Hagendorff A, Fehske W, Flachskampf FA, Helfen A, Kreidel F, Kruck S, La Rosée K, Tiemann K, Voigt J, von Bardeleben RS, Zahn R, Knebel F. Manual zur Indikation und Durchführung der Echokardiographie – Update 2020 der Deutschen Gesellschaft für Kardiologie. Kardiologe 2020;14:396-431. [DOI: 10.1007/s12181-020-00402-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
171 Salzano A, De Luca M, Israr MZ, Crisci G, Eltayeb M, Debiec R, Ranieri B, D'Assante R, Rega S, D'Agostino A, Mauro C, Squire IB, Suzuki T, Bossone E, Guazzi M, Marra AM. Exercise Intolerance in Heart Failure with Preserved Ejection Fraction. Heart Fail Clin 2021;17:397-413. [PMID: 34051972 DOI: 10.1016/j.hfc.2021.03.004] [Reference Citation Analysis]
172 Lüscher TF. Chronic coronary syndromes: genetics, shear stress, and biomarkers. Eur Heart J 2019;40:3367-71. [PMID: 33215677 DOI: 10.1093/eurheartj/ehz804] [Reference Citation Analysis]
173 Yano M, Nishino M, Ukita K, Kawamura A, Nakamura H, Matsuhiro Y, Yasumoto K, Tsuda M, Okamoto N, Tanaka A, Matsunaga-Lee Y, Egami Y, Shutta R, Tanouchi J, Yamada T, Yasumura Y, Tamaki S, Hayashi T, Nakagawa A, Nakagawa Y, Suna S, Nakatani D, Hikoso S, Sakata Y; Osaka CardioVascular Conference (OCVC)-Heart Failure Investigators. High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction. ESC Heart Fail 2021;8:2791-801. [PMID: 33934563 DOI: 10.1002/ehf2.13350] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
174 Hundertmark M. Should CMR be the default imaging modality in clinical trials for heart failure? Cardiovasc Diagn Ther 2020;10:554-8. [PMID: 32695636 DOI: 10.21037/cdt-20-244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
175 Minhas AS, Gilotra NA, Goerlich E, Metkus T, Garibaldi BT, Sharma G, Bavaro N, Phillip S, Michos ED, Hays AG. Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality. Front Cardiovasc Med 2021;8:667721. [PMID: 34195234 DOI: 10.3389/fcvm.2021.667721] [Reference Citation Analysis]
176 Donal E, L'official G, Kosmala W. Heart Failure With Preserved Ejection Fraction: Defining Phenotypes. J Card Fail 2020;26:929-31. [PMID: 32956811 DOI: 10.1016/j.cardfail.2020.09.013] [Reference Citation Analysis]
177 Lisco G, Giagulli VA, Iovino M, Zupo R, Guastamacchia E, De Pergola G, Iacoviello M, Triggiani V. Endocrine system dysfunction and chronic heart failure: a clinical perspective. Endocrine 2021. [PMID: 34713389 DOI: 10.1007/s12020-021-02912-w] [Reference Citation Analysis]
178 Guta AC, Badano LP, Ochoa-Jimenez RC, Genovese D, Previtero M, Civera S, Ruocco A, Bettella N, Parati G, Muraru D. Three-dimensional echocardiography to assess left ventricular geometry and function. Expert Rev Cardiovasc Ther 2019;17:801-15. [PMID: 31770493 DOI: 10.1080/14779072.2019.1697234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
179 Borlaug BA. Evaluation and management of heart failure with preserved ejection fraction. Nat Rev Cardiol 2020;17:559-73. [DOI: 10.1038/s41569-020-0363-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 26.0] [Reference Citation Analysis]
180 Shono A, Matsumoto K, Yamada N, Kusunose K, Suzuki M, Sumimoto K, Tanaka Y, Yamashita K, Shibata N, Yokota S, Suto M, Dokuni K, Tanaka H, Hirata KI. "Accelerated aging" of the heart as heart failure with preserved ejection fraction-analysis using leg-positive pressure stress echocardiography. Int J Cardiovasc Imaging 2021;37:2473-82. [PMID: 33939071 DOI: 10.1007/s10554-021-02258-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Bode D, Wen Y, Hegemann N, Primessnig U, Parwani A, Boldt LH, M Pieske B, R Heinzel F, Hohendanner F. Oxidative Stress and Inflammatory Modulation of Ca2+ Handling in Metabolic HFpEF-Related Left Atrial Cardiomyopathy. Antioxidants (Basel) 2020;9:E860. [PMID: 32937823 DOI: 10.3390/antiox9090860] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
182 Lüscher TF. Understanding cardiovascular disease: macrophage function, LDL-receptor trafficking, and C-type natriuretic peptide. Eur Heart J 2020;41:975-9. [PMID: 33216884 DOI: 10.1093/eurheartj/ehaa130] [Reference Citation Analysis]
183 Vaishnav JD, Yanek LR, Hahn VS, Yang E, Trivedi R, Kass DA, Sharma K. Under-Enrollment of Obese Heart Failure with Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials. J Card Fail 2021:S1071-9164(21)00500-5. [PMID: 34933099 DOI: 10.1016/j.cardfail.2021.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Bhardwaj A, Parikh VY, Nair A. Transcatheter Interatrial Shunts for the Treatment of Heart Failure with Preserved Ejection Fraction. International Journal of Cardiovascular Sciences 2021;34:81-8. [DOI: 10.36660/ijcs.20200236] [Reference Citation Analysis]
185 Longhi S, Saturi G, Caponetti AG, Gagliardi C, Biagini E. Advanced Heart Failure in a Special Population: Heart Failure with Preserved Ejection Fraction. Heart Fail Clin 2021;17:685-95. [PMID: 34511215 DOI: 10.1016/j.hfc.2021.05.012] [Reference Citation Analysis]
186 Belkin MN, Blair JE, Shah SJ, Alenghat FJ. A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction. ESC Heart Fail 2021. [PMID: 34369088 DOI: 10.1002/ehf2.13523] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
187 Tan TS, Turan Serifler N, Demirtola AI, Akbulut IM, Ozyuncu N, Vurgun VK, Esenboga K, Kurklu HA, Kozluca V, Gerede Uludag DM, Ongun A, Dincer I. Invasive validation of the left ventricular global longitudinal strain for estimating left ventricular filling pressure. Echocardiography 2021;38:1133-40. [PMID: 34114248 DOI: 10.1111/echo.15127] [Reference Citation Analysis]
188 Finet JE, Van Iterson EH, Wilson Tang WH. Invasive Hemodynamic and Metabolic Evaluation of HFpEF. Curr Treat Options Cardiovasc Med 2021;23:32. [PMID: 34177247 DOI: 10.1007/s11936-021-00904-7] [Reference Citation Analysis]
189 Cameli M, Pastore MC, Mandoli GE. Left atrial strain: A key element for the evaluation of patients with HFpEF. Int J Cardiol 2021;323:197-8. [PMID: 33027680 DOI: 10.1016/j.ijcard.2020.09.078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
190 Yap EP, Kp MMJ, Ramachandra CJ. Targeting the Metabolic-Inflammatory Circuit in Heart Failure With Preserved Ejection Fraction. Curr Heart Fail Rep 2022. [PMID: 35403986 DOI: 10.1007/s11897-022-00546-1] [Reference Citation Analysis]
191 Shi R, Shi K, Huang S, Li X, Xia CC, Li Y, He S, Li ZL, He Y, Guo YK, Yang ZG. Association Between Heart Failure With Preserved Left Ventricular Ejection Fraction and Impaired Left Atrial Phasic Function in Hypertrophic Cardiomyopathy: Evaluation by Cardiac MRI Feature Tracking. J Magn Reson Imaging 2021. [PMID: 34799953 DOI: 10.1002/jmri.28000] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Setterberg IE, Le C, Frisk M, Li J, Louch WE. The Physiology and Pathophysiology of T-Tubules in the Heart. Front Physiol 2021;12:718404. [PMID: 34566684 DOI: 10.3389/fphys.2021.718404] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Trippel TD, Mende M, Düngen HD, Hashemi D, Petutschnigg J, Nolte K, Herrmann-Lingen C, Binder L, Hasenfuss G, Pieske B, Wachter R, Edelmann F. The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF study. ESC Heart Fail 2021;8:829-41. [PMID: 33566456 DOI: 10.1002/ehf2.13174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
194 Scheffer M, Driessen-Waaijer A, Hamdani N, Landzaat JWD, Jonkman NH, Paulus WJ, van Heerebeek L. Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA-HFpEF trial. ESC Heart Fail 2020. [PMID: 33073523 DOI: 10.1002/ehf2.13055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
195 Yan Y, Mao M, Li YQ, Chen YJ, Yu HD, Xie WZ, Huang Q, Leng WD, Xiong J. Periodontitis Is Associated With Heart Failure: A Population-Based Study (NHANES III). Front Physiol 2022;13:854606. [PMID: 35514329 DOI: 10.3389/fphys.2022.854606] [Reference Citation Analysis]
196 Weerts J, Barandiarán Aizpurua A, Henkens MTHM, Lyon A, van Mourik MJW, van Gemert MRAA, Raafs A, Sanders-van Wijk S, Bayés-Genís A, Heymans SRB, Crijns HJGM, Brunner-La Rocca HP, Lumens J, van Empel VPM, Knackstedt C. The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fraction. Eur Heart J Cardiovasc Imaging 2021:jeab222. [PMID: 34718457 DOI: 10.1093/ehjci/jeab222] [Reference Citation Analysis]
197 Del Torto A, Guaricci AI, Pomarico F, Guglielmo M, Fusini L, Monitillo F, Santoro D, Vannini M, Rossi A, Muscogiuri G, Baggiano A, Pontone G. Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2022;9:758975. [DOI: 10.3389/fcvm.2022.758975] [Reference Citation Analysis]
198 Rethy L, Borlaug BA, Redfield MM, Oh JK, Shah SJ, Patel RB. Application of Guideline-Based Echocardiographic Assessment of Left Atrial Pressure to Heart Failure with Preserved Ejection Fraction. J Am Soc Echocardiogr 2021;34:455-64. [PMID: 33359021 DOI: 10.1016/j.echo.2020.12.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
199 Putot S, Hacquin A, Manckoundia P, Putot A. Prognostic impact of systolic blood pressure in acute heart failure with preserved ejection fraction in older patients. ESC Heart Fail 2021;8:5493-500. [PMID: 34664426 DOI: 10.1002/ehf2.13650] [Reference Citation Analysis]
200 Donal E, Paven E, Galli E. Combined exercise and imaging: key tool for clinical challenges. Heart 2020;106:1041-2. [PMID: 32341136 DOI: 10.1136/heartjnl-2020-316979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
201 Cleland JGF, Lyon AR, McDonagh T, McMurray JJV. The year in cardiology: heart failure. Eur Heart J 2020;41:1232-48. [PMID: 31901936 DOI: 10.1093/eurheartj/ehz949] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
202 Amanai S, Harada T, Kagami K, Yoshida K, Kato T, Wada N, Obokata M. The H2FPEF and HFA-PEFF algorithms for predicting exercise intolerance and abnormal hemodynamics in heart failure with preserved ejection fraction. Sci Rep 2022;12:13. [PMID: 34996984 DOI: 10.1038/s41598-021-03974-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Guazzi M, Naeije R. Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail 2021;14:e007840. [PMID: 33866826 DOI: 10.1161/CIRCHEARTFAILURE.120.007840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Frisk M, Le C, Shen X, Røe ÅT, Hou Y, Manfra O, Silva GJJ, van Hout I, Norden ES, Aronsen JM, Laasmaa M, Espe EKS, Zouein FA, Lambert RR, Dahl CP, Sjaastad I, Lunde IG, Coffey S, Cataliotti A, Gullestad L, Tønnessen T, Jones PP, Altara R, Louch WE. Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol 2021;77:405-19. [PMID: 33509397 DOI: 10.1016/j.jacc.2020.11.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
205 Zhang B, Xu Y, Cui X, Jiang H, Luo W, Weng X, Wang Y, Zhao Y, Sun A, Ge J. Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2021;8:647806. [PMID: 33748197 DOI: 10.3389/fcvm.2021.647806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
206 Pugliese NR, Rosada J, Masi S. Train the brain to preserve the heart: the link between education and heart failure. Int J Cardiol 2021;326:202-5. [PMID: 33130258 DOI: 10.1016/j.ijcard.2020.10.066] [Reference Citation Analysis]
207 Severino P, D'Amato A, Prosperi S, Fanisio F, Birtolo LI, Costi B, Netti L, Chimenti C, Lavalle C, Maestrini V, Mancone M, Fedele F. Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets. Int J Mol Sci 2021;22:7650. [PMID: 34299270 DOI: 10.3390/ijms22147650] [Reference Citation Analysis]
208 Shahim A, Hourqueig M, Donal E, Oger E, Venkateshvaran A, Daubert JC, Savarese G, Linde C, Lund LH, Hage C. Predictors of long-term outcome in heart failure with preserved ejection fraction: a follow-up from the KaRen study. ESC Heart Fail 2021. [PMID: 34374216 DOI: 10.1002/ehf2.13533] [Reference Citation Analysis]
209 Leggat J, Bidault G, Vidal-Puig A. Lipotoxicity: a driver of heart failure with preserved ejection fraction? Clin Sci (Lond) 2021;135:2265-83. [PMID: 34643676 DOI: 10.1042/CS20210127] [Reference Citation Analysis]
210 Wang W, Mu G, Liu C, Xie J, Zhang H, Zhang X, Che J, Tse G, Liu T, Li G, Fu H. A Novel Three-Dimensional and Tissue Doppler Echocardiographic Index for Diagnosing and Prognosticating Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2022;9:822314. [DOI: 10.3389/fcvm.2022.822314] [Reference Citation Analysis]
211 Fu L, Zhou Y, Sun J, Zhu Z, Tai S, Tomlinson B. Abdominal Obesity Is Associated with an Increased Risk of All-Cause Mortality in Males but Not in Females with HFpEF. Cardiovascular Therapeutics 2022;2022:1-11. [DOI: 10.1155/2022/2950055] [Reference Citation Analysis]
212 Cho DH, Yoo BS. Current Prevalence, Incidence, and Outcomes of Heart Failure with Preserved Ejection Fraction. Heart Fail Clin 2021;17:315-26. [PMID: 34051964 DOI: 10.1016/j.hfc.2021.03.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
213 Chi C, Liu Y, Xu Y, Xu D. Association Between Arterial Stiffness and Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2021;8:707162. [PMID: 34458336 DOI: 10.3389/fcvm.2021.707162] [Reference Citation Analysis]
214 Stubbs H, MacLellan A, McGettrick M, Jani B, Brewis M, Church C, Johnson M. Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland. Open Heart 2022;9:e002023. [PMID: 35477699 DOI: 10.1136/openhrt-2022-002023] [Reference Citation Analysis]
215 Stubbe B, Seyfarth HJ, Kleymann J, Halank M, Al Ghorani H, Obst A, Desole S, Ewert R, Opitz CF. Monotherapy in patients with pulmonary arterial hypertension at four German PH centres. BMC Pulm Med 2021;21:130. [PMID: 33882879 DOI: 10.1186/s12890-021-01499-2] [Reference Citation Analysis]
216 Tschöpe C, Elsanhoury A, Nelki V, Van Linthout S, Kelle S, Remppis A. [Heart failure with preserved ejection fraction as a model disease for the cardio-pulmonary-renal syndrome : Importance of visceral fat expansion as central pathomechanism]. Internist (Berl) 2021;62:1141-52. [PMID: 34613426 DOI: 10.1007/s00108-021-01182-y] [Reference Citation Analysis]
217 Lee SH, Choi KH, Song YB, Jeong DS, Yang JH, Kim WS, Lee YT. Comprehensive assessment of heart failure in patients with preserved ejection fraction undergoing coronary bypass grafting. J Thorac Cardiovasc Surg 2021:S0022-5223(21)00980-6. [PMID: 34217536 DOI: 10.1016/j.jtcvs.2021.06.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Shchendrygina AA, Zhbanov KA, Privalova EV, Yusupova AO, Danilogorskaya YA, Salakheeva EY, Sokolova IY, Tsatsurova SA, Ageeva AA, Belenkov YN. Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches. Racionalʹnaâ farmakoterapiâ v kardiologii 2021;17:476-83. [DOI: 10.20996/1819-6446-2021-05-01] [Reference Citation Analysis]
219 Galati G, Sabouret P, Germanova O, Bhatt DL. Women and Diabetes: Preventing Heart Disease in a New Era of Therapies. Eur Cardiol 2021;16:e40. [PMID: 34777580 DOI: 10.15420/ecr.2021.22] [Reference Citation Analysis]
220 van der Aart-van der Beek AB, de Boer RA, Heerspink HJL. Kidney and heart failure outcomes associated with SGLT2 inhibitor use. Nat Rev Nephrol 2022. [PMID: 35145275 DOI: 10.1038/s41581-022-00535-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
221 Guazzi M. The Link Between Heart Rate, Exercise, and β-Blocker in HFpEF: Time to Untie the Knot. J Am Coll Cardiol 2021;78:2057-9. [PMID: 34794686 DOI: 10.1016/j.jacc.2021.09.018] [Reference Citation Analysis]
222 Songsangjinda T, Krittayaphong R. Impact of different degrees of left ventricular strain on left atrial mechanics in heart failure with preserved ejection fraction. BMC Cardiovasc Disord 2022;22. [DOI: 10.1186/s12872-022-02608-7] [Reference Citation Analysis]
223 Harada T, Araki T, Sunaga H, Kagami K, Yoshida K, Kato T, Kawakami R, Tomono J, Wada N, Iso T, Kurabayashi M, Obokata M. Pathophysiological and diagnostic importance of fatty acid-binding protein 1 in heart failure with preserved ejection fraction. Sci Rep 2021;11:21175. [PMID: 34707207 DOI: 10.1038/s41598-021-00760-2] [Reference Citation Analysis]
224 Chiou YA, Hung CL, Lin SF. AI-Assisted Echocardiographic Prescreening of Heart Failure With Preserved Ejection Fraction on the Basis of Intrabeat Dynamics. JACC Cardiovasc Imaging 2021:S1936-878X(21)00422-8. [PMID: 34147456 DOI: 10.1016/j.jcmg.2021.05.005] [Reference Citation Analysis]
225 Nayor M, Houstis NE, Namasivayam M, Rouvina J, Hardin C, Shah RV, Ho JE, Malhotra R, Lewis GD. Impaired Exercise Tolerance in Heart Failure With Preserved Ejection Fraction: Quantification of Multiorgan System Reserve Capacity. JACC Heart Fail 2020;8:605-17. [PMID: 32535122 DOI: 10.1016/j.jchf.2020.03.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
226 Stassen J, Ewe SH, Butcher SC, Amanullah MR, Mertens BJ, Hirasawa K, Singh GK, Sin KY, Ding ZP, Pio SM, Sia CH, Chew N, Kong W, Poh KK, Cohen D, Généreux P, Leon MB, Ajmone Marsan N, Delgado V, Bax JJ. Prognostic implications of left ventricular diastolic dysfunction in moderate aortic stenosis. Heart 2022:heartjnl-2022-320886. [PMID: 35688475 DOI: 10.1136/heartjnl-2022-320886] [Reference Citation Analysis]
227 Maeder MT. Editorial Commentary: Biomarkers of cardiovascular risk in obstructive sleep apnea - innovation or illusion? Trends Cardiovasc Med 2021;31:250-1. [PMID: 32437867 DOI: 10.1016/j.tcm.2020.04.009] [Reference Citation Analysis]
228 Berezin AA, Lichtenauer M, Boxhammer E, Fushtey IM, Berezin AE. Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus. Front Physiol 2022;13:922775. [DOI: 10.3389/fphys.2022.922775] [Reference Citation Analysis]
229 Martens P, Claessen G, Van De Bruaene A, Verbrugge FH, Herbots L, Dendale P, Verwerft J. Iron Deficiency Is Associated With Impaired Biventricular Reserve and Reduced Exercise Capacity in Patients With Unexplained Dyspnea. J Card Fail 2021;27:766-76. [PMID: 33838251 DOI: 10.1016/j.cardfail.2021.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Arques S, Quennelle F, Roux E. Accuracy of peak mitral e-wave velocity in the diagnosis of heart failure with preserved ejection fraction in older patients with acute dyspnea. Ann Cardiol Angeiol (Paris) 2021;70:281-5. [PMID: 34130805 DOI: 10.1016/j.ancard.2021.05.008] [Reference Citation Analysis]
231 Tanacli R, Hashemi D, Neye M, Motzkus LA, Blum M, Tahirovic E, Dordevic A, Kraft R, Zamani SM, Pieske B, Düngen HD, Kelle S. Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction. ESC Heart Fail 2020;7:3240-5. [PMID: 32567247 DOI: 10.1002/ehf2.12826] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
232 Fraser AG, Szymański P. Heart valve disease, left ventricular hypertrophy, and heart failure: a lifelong relationship and continuing clinical responsibility. Eur J Heart Fail 2021;23:2017-20. [PMID: 34693608 DOI: 10.1002/ejhf.2373] [Reference Citation Analysis]
233 Andersson C, Liu C, Cheng S, Wang TJ, Gerszten RE, Larson MG, Vasan RS. Metabolomic signatures of cardiac remodelling and heart failure risk in the community. ESC Heart Fail 2020. [PMID: 32909388 DOI: 10.1002/ehf2.12923] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
234 Fraser AG, Girerd N. Cardiovascular imaging "guidelines" - High time for a paradigm shift. Int J Cardiol 2021;329:246-8. [PMID: 33359285 DOI: 10.1016/j.ijcard.2020.12.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
235 Aizawa N, Konishi M, Kitai T, Tsujisaka Y, Kawase Y, Shimada N, Tamura K, Kimura K, Ohya Y. Infrequent use of nighttime dialysis for emergency admission due to worsening heart failure in patients on maintenance hemodialysis. Ther Apher Dial 2022;26:85-93. [PMID: 33686756 DOI: 10.1111/1744-9987.13644] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
236 Parcha V, Malla G, Kalra R, Patel N, Sanders-van Wijk S, Pandey A, Shah SJ, Arora G, Arora P. Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems. ESC Heart Fail 2021;8:2089-102. [PMID: 33709628 DOI: 10.1002/ehf2.13288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
237 Katbeh A, De Potter T, Geelen P, Di Gioia G, Kodeboina M, Balogh Z, Albano M, Vanderheyden M, Bartunek J, Barbato E, Van Camp G, Penicka M. Heart failure with preserved ejection fraction or non-cardiac dyspnea in paroxysmal atrial fibrillation: The role of left atrial strain. Int J Cardiol 2021;323:161-7. [PMID: 32882295 DOI: 10.1016/j.ijcard.2020.08.093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
238 Remmelzwaal S, van Ballegooijen AJ, Schoonmade LJ, Dal Canto E, Handoko ML, Henkens MTHM, van Empel V, Heymans SRB, Beulens JWJ. Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction-a systematic review and meta-analysis. BMC Med 2020;18:290. [PMID: 33121502 DOI: 10.1186/s12916-020-01764-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
239 Sunderji I, Singh V, Fraser AG. When does the E/e’ index not work? The pitfalls of oversimplifying diastolic function. Echocardiography 2020;37:1897-907. [DOI: 10.1111/echo.14697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
240 D'Alto M, Badesch D, Bossone E, Borlaug BA, Brittain E, Humbert M, Naeije R. A Fluid Challenge Test for the Diagnosis of Occult Heart Failure. Chest 2021;159:791-7. [PMID: 32805242 DOI: 10.1016/j.chest.2020.08.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
241 Henkens MTHM, Remmelzwaal S, Robinson EL, van Ballegooijen AJ, Barandiarán Aizpurua A, Verdonschot JAJ, Raafs AG, Weerts J, Hazebroek MR, Sanders-van Wijk S, Handoko ML, den Ruijter HM, Lam CSP, de Boer RA, Paulus WJ, van Empel VPM, Vos R, Brunner-La Rocca HP, Beulens JWJ, Heymans SRB. Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review. Eur J Heart Fail 2020;22:1586-97. [PMID: 32592317 DOI: 10.1002/ejhf.1944] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
242 Oghina S, Bougouin W, Kharoubi M, Bonnefous L, Galat A, Guendouz S, Bezard M, Le Bras F, Deux JF, Itti E, Moktefi A, Fanen P, Teiger E, Mohty D, Damy T, Bodez D. Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation. J Clin Med 2021;10:4888. [PMID: 34768408 DOI: 10.3390/jcm10214888] [Reference Citation Analysis]
243 Grigorian-Shamagian L, Sanz-Ruiz R, Climent A, Badimon L, Barile L, Bolli R, Chamuleau S, Grobbee DE, Janssens S, Kastrup J, Kragten-Tabatabaie L, Madonna R, Mathur A, Menasché P, Pompilio G, Prosper F, Sena E, Smart N, Zimmermann WH, Fernández-Avilés F. Insights into therapeutic products, preclinical research models, and clinical trials in cardiac regenerative and reparative medicine: where are we now and the way ahead. Current opinion paper of the ESC Working Group on Cardiovascular Regenerative and Reparative Medicine. Cardiovasc Res 2021;117:1428-33. [PMID: 33258961 DOI: 10.1093/cvr/cvaa337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
244 Tadic M, Cuspidi C. Left atrial function in diabetes: does it help? Acta Diabetol 2021;58:131-7. [PMID: 32519220 DOI: 10.1007/s00592-020-01557-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
245 Wang S, Li M, Wang X, Luo J, Zou Y, Hu Y, Liu X, Ao H, Yao X, Li C, Yang T. The Ratio of NT-proBNP to CysC1.53 Predicts Heart Failure in Patients With Chronic Kidney Disease. Front Cardiovasc Med 2021;8:731864. [PMID: 34869631 DOI: 10.3389/fcvm.2021.731864] [Reference Citation Analysis]
246 Piskorz D, Keller L, Citta L, Mata L, Citta N, Bongarzoni L, Citta P. Medium to Long Term Follow-Up of Treated Hypertensive Mediated Heart Disease. High Blood Press Cardiovasc Prev 2021;28:383-91. [PMID: 33950510 DOI: 10.1007/s40292-021-00457-7] [Reference Citation Analysis]
247 Lüscher TF. Ejection fraction to classify heart failure: are we using the right thing? Eur Heart J 2020;41:1219-22. [PMID: 33216868 DOI: 10.1093/eurheartj/ehaa205] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
248 Jain CC, Tschirren J, Reddy YNV, Melenovsky V, Redfield M, Borlaug BA. Subclinical Pulmonary Congestion and Abnormal Hemodynamics in Heart Failure With Preserved Ejection Fraction. JACC Cardiovasc Imaging 2021:S1936-878X(21)00702-6. [PMID: 34801461 DOI: 10.1016/j.jcmg.2021.09.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
249 Piccini JP, Fudim M, Black-Maier E. Can catheter ablation of atrial fibrillation reverse heart failure with preserved ejection fraction? J Cardiovasc Electrophysiol 2021;32:2368-70. [PMID: 34379342 DOI: 10.1111/jce.15205] [Reference Citation Analysis]
250 Chiabrando JG, Feola M. Exercise and adverse ventricular remodeling: the cornerstone of heart failure. Minerva Cardiol Angiol 2021;69:435-7. [PMID: 33427422 DOI: 10.23736/S2724-5683.20.05442-0] [Reference Citation Analysis]
251 Kato T, Harada T, Kagami K, Obokata M. The roles of global longitudinal strain imaging in contemporary clinical cardiology. J Med Ultrason (2001) 2022. [PMID: 35088169 DOI: 10.1007/s10396-021-01184-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Zagatina A, Zhuravskaya N, Shmatov D, Ciampi Q, Carpeggiani C, Picano E; the Stress Echo 2020 study group of the Italian Society of Echocardiography, Cardiovascular Imaging. Exercise stress echocardiography with ABCDE protocol in unexplained dyspnoea. Int J Cardiovasc Imaging 2020;36:823-31. [DOI: 10.1007/s10554-020-01789-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
253 Vanhentenrijk S, Verbrugge FH. New Hemodynamic Insights in Pulmonary Vascular Disease and Heart Failure with Preserved Ejection Fraction. Curr Treat Options Cardio Med 2021;23. [DOI: 10.1007/s11936-021-00900-x] [Reference Citation Analysis]
254 Sperlongano S, D'Andrea A, Mele D, Russo V, Pergola V, Carbone A, Ilardi F, Di Maio M, Bottino R, Giallauria F, Bossone E, Golino P. Left Ventricular Deformation and Vortex Analysis in Heart Failure: From Ultrasound Technique to Current Clinical Application. Diagnostics (Basel) 2021;11:892. [PMID: 34067703 DOI: 10.3390/diagnostics11050892] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
255 He J, Sirajuddin A, Li S, Zhuang B, Xu J, Zhou D, Wu W, Sun X, Fan X, Ji K, Chen L, Zhao S, Arai AE, Lu M. Heart Failure With Preserved Ejection Fraction in Hypertension Patients: A Myocardial MR Strain Study. J Magn Reson Imaging 2021;53:527-39. [PMID: 32896042 DOI: 10.1002/jmri.27313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
256 Henkens MTHM, van Ommen AM, Remmelzwaal S, Valstar GB, Wang P, Verdonschot JAJ, Hazebroek MR, Hofstra L, van Empel VPM, Beulens JWJ, den Ruijter HM, Heymans SRB. The HFA-PEFF score identifies 'early-HFpEF' phenogroups associated with distinct biomarker profiles. ESC Heart Fail 2022. [PMID: 35301820 DOI: 10.1002/ehf2.13861] [Reference Citation Analysis]
257 Hedman ÅK, Hage C, Sharma A, Brosnan MJ, Buckbinder L, Gan L, Shah SJ, Linde CM, Donal E, Daubert J, Mälarstig A, Ziemek D, Lund L. Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning. Heart 2020;106:342-9. [DOI: 10.1136/heartjnl-2019-315481] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
258 Mincu RI, Lampe LF, Mahabadi AA, Kimmig R, Rassaf T, Totzeck M. Left Ventricular Diastolic Function Following Anthracycline-Based Chemotherapy in Patients with Breast Cancer without Previous Cardiac Disease-A Meta-Analysis. J Clin Med 2021;10:3890. [PMID: 34501337 DOI: 10.3390/jcm10173890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Oakland HT, Joseph P, Elassal A, Cullinan M, Heerdt PM, Singh I. Diagnostic utility of sub-maximum cardiopulmonary exercise testing in the ambulatory setting for heart failure with preserved ejection fraction. Pulm Circ 2020;10:2045894020972273. [PMID: 33282205 DOI: 10.1177/2045894020972273] [Reference Citation Analysis]
260 Schnelle M, Leha A, Eidizadeh A, Fuhlrott K, Trippel TD, Hashemi D, Toischer K, Wachter R, Herrmann-Lingen C, Hasenfuß G, Pieske B, Binder L, Edelmann F. Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial. Cells 2021;10:2796. [PMID: 34685778 DOI: 10.3390/cells10102796] [Reference Citation Analysis]
261 Task Force for the management of COVID-19 of the European Society of Cardiology . European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Cardiovasc Res 2021:cvab342. [PMID: 34864874 DOI: 10.1093/cvr/cvab342] [Reference Citation Analysis]
262 Smiseth OA, Morris DA, Cardim N, Cikes M, Delgado V, Donal E, Flachskampf FA, Galderisi M, Gerber BL, Gimelli A, Klein AL, Knuuti J, Lancellotti P, Mascherbauer J, Milicic D, Seferovic P, Solomon S, Edvardsen T, Popescu BA; Reviewers: This document was reviewed by members of the 2018–2020 EACVI Scientific Documents Committee: Philippe B. Bertrand, Marc Dweck, Kristina H. Haugaa, Leyla Elif Sade, Ivan Stankovic; by external reviewers: Jong-Won Ha, Sherif Nagueh, Jae K. Oh, Nobuyuki Ohte; and by the 2020–2022 EACVI President: Bernard Cosyns. Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2021:jeab154. [PMID: 34729586 DOI: 10.1093/ehjci/jeab154] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Aldaas OM, Malladi CL, Hsu JC. Atrial fibrillation in patients with heart failure with preserved ejection fraction. Curr Opin Cardiol 2020;35:260-70. [PMID: 32102085 DOI: 10.1097/HCO.0000000000000732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
264 Baratto C, Caravita S, Soranna D, Faini A, Dewachter C, Zambon A, Perego GB, Bondue A, Senni M, Badano LP, Parati G, Vachiéry JL. Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction. Circ Heart Fail 2021;14:e007555. [PMID: 33951935 DOI: 10.1161/CIRCHEARTFAILURE.120.007555] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
265 Fraser AG, Tschöpe C, de Boer RA. Diagnostic recommendations and phenotyping for heart failure with preserved ejection fraction: knowing more and understanding less? Eur J Heart Fail 2021;23:964-72. [PMID: 33928729 DOI: 10.1002/ejhf.2205] [Reference Citation Analysis]
266 Bernardo RJ, Haddad F, Couture EJ, Hansmann G, de Jesus Perez VA, Denault AY, de Man FS, Amsallem M. Mechanics of right ventricular dysfunction in pulmonary arterial hypertension and heart failure with preserved ejection fraction. Cardiovasc Diagn Ther 2020;10:1580-603. [PMID: 33224775 DOI: 10.21037/cdt-20-479] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
267 Withaar C, Meems LMG, Markousis-Mavrogenis G, Boogerd CJ, Silljé HHW, Schouten EM, Dokter MM, Voors AA, Westenbrink BD, Lam CSP, de Boer RA. The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction. Cardiovasc Res 2021;117:2108-24. [PMID: 32871009 DOI: 10.1093/cvr/cvaa256] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
268 Verbrugge FH, Guazzi M, Testani JM, Borlaug BA. Altered Hemodynamics and End-Organ Damage in Heart Failure: Impact on the Lung and Kidney. Circulation 2020;142:998-1012. [PMID: 32897746 DOI: 10.1161/CIRCULATIONAHA.119.045409] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 10.5] [Reference Citation Analysis]
269 Withaar C, Lam CSP, Schiattarella GG, de Boer RA, Meems LMG. Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models. Eur Heart J 2021:ehab389. [PMID: 34414416 DOI: 10.1093/eurheartj/ehab389] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
270 Nagel E, Carerj ML, Arendt CT, Puntmann VO. After ISCHEMIA: Is cardiac MRI a reliable gatekeeper for invasive angiography and myocardial revascularization? Herz 2020;45:446-52. [PMID: 32458013 DOI: 10.1007/s00059-020-04936-w] [Reference Citation Analysis]
271 Arques S, Chelaifa H, Vieillard M, Roux E. Clinical relevance of spectral tissue Doppler-derived E/e' in older patients with preserved ejection fraction. Ann Cardiol Angeiol (Paris) 2021:S0003-3928(21)00067-6. [PMID: 34130804 DOI: 10.1016/j.ancard.2021.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
272 Meems LMG, van Veldhuisen DJ, de Boer RA. Progress in heart failure management in the Netherlands and beyond: long-term commitment to deliver high-quality research and patient care. Neth Heart J 2020;28:31-8. [PMID: 32780329 DOI: 10.1007/s12471-020-01453-7] [Reference Citation Analysis]
273 Nishi T, Kobayashi Y, Christle JW, Cauwenberghs N, Boralkar K, Moneghetti K, Amsallem M, Hedman K, Contrepois K, Myers J, Mahaffey KW, Schnittger I, Kuznetsova T, Palaniappan L, Haddad F. Incremental value of diastolic stress test in identifying subclinical heart failure in patients with diabetes mellitus. Eur Heart J Cardiovasc Imaging 2020;21:876-84. [PMID: 32386203 DOI: 10.1093/ehjci/jeaa070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
274 Paukovitsch M, Schneider LM, Reichart C, Nita N, Rottbauer W, Keßler M, Markovic S. Prevalence of iatrogenic atrial septal defects (iASD) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) in the long-term follow-up. Open Heart 2021;8:e001732. [PMID: 34702777 DOI: 10.1136/openhrt-2021-001732] [Reference Citation Analysis]
275 von der Born J, Baberowski S, Memaran N, Grams L, Homeyer D, Borchert-Mörlins B, Sugianto RI, Paulsen M, Bauer E, Grabitz C, Schmidt BMW, Kerling A, Beerbaum P, Stiesch M, Tegtbur U, Melk A. Impact of Sex and Obesity on Echocardiographic Parameters in Children and Adolescents. Pediatr Cardiol 2022. [PMID: 35394150 DOI: 10.1007/s00246-022-02876-2] [Reference Citation Analysis]
276 Tocci G. Antihypertensive Efficacy of LCZ696 (Sacubitril/Valsartan) in Hypertension. Cardiology 2020;145:599-600. [PMID: 32615561 DOI: 10.1159/000508345] [Reference Citation Analysis]
277 Kapłon-Cieślicka A, Laroche C, Crespo-Leiro MG, Coats AJS, Anker SD, Filippatos G, Maggioni AP, Hage C, Lara-Padrón A, Fucili A, Drożdż J, Seferovic P, Rosano GMC, Mebazaa A, McDonagh T, Lainscak M, Ruschitzka F, Lund LH; Heart Failure Association (HFA) of the European Society of Cardiology (ESC) and the ESC Heart Failure Long-Term Registry Investigators. Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry. ESC Heart Fail 2020;7:2098-112. [PMID: 32618139 DOI: 10.1002/ehf2.12817] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
278 Jain CC, Borlaug BA. Performance and Interpretation of Invasive Hemodynamic Exercise Testing. Chest 2020;158:2119-29. [PMID: 32473950 DOI: 10.1016/j.chest.2020.05.552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
279 Crea F. The growing role of genetics in the understanding of cardiovascular diseases: towards personalized medicine. Eur Heart J 2021;42:1929-33. [PMID: 34020446 DOI: 10.1093/eurheartj/ehab279] [Reference Citation Analysis]
280 Miyagi C, Miyamoto T, Kuroda T, Karimov JH, Starling RC, Fukamachi K. Large animal models of heart failure with preserved ejection fraction. Heart Fail Rev 2021. [PMID: 34751846 DOI: 10.1007/s10741-021-10184-9] [Reference Citation Analysis]
281 Parry M, Van Spall HG, Mullen K, Mulvagh SL, Pacheco C, Colella TJ, Clavel M, Jaffer S, Foulds HJ, Grewal J, Hardy M, Price JA, Levinsson AL, Gonsalves CA, Norris CM. The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women-Chapter 6: Sex- And Gender-Specific Diagnosis and Treatment. CJC Open 2022. [DOI: 10.1016/j.cjco.2022.04.002] [Reference Citation Analysis]
282 Rahmouni K, Rubens FD. Commentary: One cannot fix what one cannot see. J Thorac Cardiovasc Surg 2021:S0022-5223(21)01015-1. [PMID: 34281704 DOI: 10.1016/j.jtcvs.2021.06.060] [Reference Citation Analysis]
283 Popescu MR, Dudu A, Jurcut C, Ciobanu AM, Zagrean AM, Panaitescu AM. A Broader Perspective on Anti-Ro Antibodies and Their Fetal Consequences-A Case Report and Literature Review. Diagnostics (Basel) 2020;10:E478. [PMID: 32674462 DOI: 10.3390/diagnostics10070478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
284 Donal E, Panis V, Kosmala W. Exercise stress echocardiography: a great tool that can be adapted to the clinical question? Open Heart 2021;8:e001641. [PMID: 33888594 DOI: 10.1136/openhrt-2021-001641] [Reference Citation Analysis]
285 Hafez MS, El Missiri AM. Left Atrial Ejection Force as a Marker for the Diagnosis of Heart Failure with Preserved Ejection Fraction. J Cardiovasc Echogr 2021;31:125-30. [PMID: 34900546 DOI: 10.4103/jcecho.jcecho_142_20] [Reference Citation Analysis]
286 Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology 2022. [DOI: 10.1016/j.jacc.2021.12.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
287 Lechner K, Scherr J, Lorenz E, Lechner B, Haller B, Krannich A, Halle M, Wachter R, Duvinage A, Edelmann F. Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial. Clin Res Cardiol 2021. [PMID: 34453204 DOI: 10.1007/s00392-021-01925-9] [Reference Citation Analysis]
288 Sorimachi H, Obokata M, Takahashi N, Reddy YNV, Jain CC, Verbrugge FH, Koepp KE, Khosla S, Jensen MD, Borlaug BA. Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction. Eur Heart J 2021;42:1595-605. [PMID: 33227126 DOI: 10.1093/eurheartj/ehaa823] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
289 Remmelzwaal S, Beulens JWJ, Elders PJM, Stehouwer CDA, Handoko ML, Appelman Y, van Empel V, Heymans SRB, van Ballegooijen AJ. Sex-specific associations of body composition measures with cardiac function and structure after 8 years of follow-up. Sci Rep 2021;11:21046. [PMID: 34702868 DOI: 10.1038/s41598-021-00541-x] [Reference Citation Analysis]
290 Sugumar H, Nanayakkara S, Vizi D, Wright L, Chieng D, Leet A, Mariani JA, Voskoboinik A, Prabhu S, Taylor AJ, Kalman JM, Kistler PM, Kaye DM, Ling LH. A prospective STudy using invAsive haemodynamic measurements foLLowing catheter ablation for AF and early HFpEF: STALL AF-HFpEF. Eur J Heart Fail 2021;23:785-96. [PMID: 33565197 DOI: 10.1002/ejhf.2122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
291 Güder G, Ertl G, Angermann CE. [Diagnostics and treatment of chronic heart failure : Update 2020]. Herz 2020. [PMID: 32016486 DOI: 10.1007/s00059-019-04877-z] [Reference Citation Analysis]
292 Okamoto C, Tsukamoto O, Hasegawa T, Hitsumoto T, Matsuoka K, Takashima S, Amaki M, Kanzaki H, Izumi C, Ito S, Kitakaze M. Lower B-type natriuretic peptide levels predict left ventricular concentric remodelling and insulin resistance. ESC Heart Fail 2021. [PMID: 34786876 DOI: 10.1002/ehf2.13700] [Reference Citation Analysis]
293 Kristensen SL, McMurray JJV. Diagnosing heart failure with preserved ejection fraction - what's the score? Eur J Heart Fail 2020;22:425-7. [PMID: 32086989 DOI: 10.1002/ejhf.1764] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
294 Zhang H, Hu W, Wang Y, Liu J, You L, Dong Q, Chang G, Cheng X, Liu Z, Zhang D. The relationship between ambulatory arterial stiffness index and left ventricular diastolic dysfunction in HFpEF: a prospective observational study. BMC Cardiovasc Disord 2022;22. [DOI: 10.1186/s12872-022-02679-6] [Reference Citation Analysis]
295 Čelutkienė J, Spoletini I, Coats AJS, Chioncel O. Left ventricular function monitoring in heart failure. Eur Heart J Suppl 2019;21:M17-9. [PMID: 31908610 DOI: 10.1093/eurheartj/suz218] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
296 Gevaert AB, Kataria R, Zannad F, Sauer AJ, Damman K, Sharma K, Shah SJ, Van Spall HGC. Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management. Heart 2022:heartjnl-2021-319605. [PMID: 35022210 DOI: 10.1136/heartjnl-2021-319605] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
297 Fu S, Xu Z, Lin B, Chen J, Huang Q, Xu Y, Xu A, Chen Y, Tang Y. Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis. Front Med (Lausanne) 2021;8:657067. [PMID: 34235161 DOI: 10.3389/fmed.2021.657067] [Reference Citation Analysis]
298 Reddy YN, Borlaug BA. Left atrial myopathy in heart failure with preserved ejection fraction. Eur J Heart Fail 2020;22:486-8. [DOI: 10.1002/ejhf.1688] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
299 Kapłon-Cieślicka A, Kupczyńska K, Dobrowolski P, Michalski B, Jaguszewski MJ, Banasiak W, Burchardt P, Chrzanowski Ł, Darocha S, Domienik-Karłowicz J, Drożdż J, Fijałkowski M, Filipiak KJ, Gruchała M, Jankowska EA, Jankowski P, Kasprzak JD, Kosmala W, Lipiec P, Mitkowski P, Mizia-Stec K, Szymański P, Tycińska A, Wańha W, Wybraniec M, Witkowski A, Ponikowski P, "Club 30" Of The Polish Cardiac Society OBO. On the search for the right definition of heart failure with preserved ejection fraction. Cardiol J 2020;27:449-68. [PMID: 32986238 DOI: 10.5603/CJ.a2020.0124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
300 Guo Y, Xiao C, Zhao K, He Z, Liu S, Wu X, Shi S, Chen Z, Shi R. Physical Exercise Modalities for the Management of Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. J Cardiovasc Pharmacol 2022;79:698-710. [PMID: 35522702 DOI: 10.1097/FJC.0000000000001254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
301 Heinzel FR, Hegemann N, Hohendanner F, Primessnig U, Grune J, Blaschke F, de Boer RA, Pieske B, Schiattarella GG, Kuebler WM. Left ventricular dysfunction in heart failure with preserved ejection fraction-molecular mechanisms and impact on right ventricular function. Cardiovasc Diagn Ther 2020;10:1541-60. [PMID: 33224773 DOI: 10.21037/cdt-20-477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
302 Florijn BW, Valstar GB, Duijs JMGJ, Menken R, Cramer MJ, Teske AJ, Ghossein-Doha C, Rutten FH, Spaanderman MEA, den Ruijter HM, Bijkerk R, van Zonneveld AJ. Sex-specific microRNAs in women with diabetes and left ventricular diastolic dysfunction or HFpEF associate with microvascular injury. Sci Rep 2020;10:13945. [PMID: 32811874 DOI: 10.1038/s41598-020-70848-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
303 Lüscher TF. Heart failure with preserved ejection fraction: towards an understanding of an enigma. European Heart Journal 2019;40:3277-80. [DOI: 10.1093/eurheartj/ehz756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
304 Tsutsui H, Ide T, Ito H, Kihara Y, Kinugawa K, Kinugawa S, Makaya M, Murohara T, Node K, Saito Y, Sakata Y, Shimizu W, Yamamoto K, Bando Y, Iwasaki YK, Kinugasa Y, Mizote I, Nakagawa H, Oishi S, Okada A, Tanaka A, Akasaka T, Ono M, Kimura T, Kosaka S, Kosuge M, Momomura SI. JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure. J Card Fail 2021:S1071-9164(21)00208-6. [PMID: 34600838 DOI: 10.1016/j.cardfail.2021.04.023] [Reference Citation Analysis]
305 Rosch S, Rommel KP, Scholz M, Thiele H, Lurz P. Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives. Card Fail Rev 2020;6:e24. [PMID: 33042584 DOI: 10.15420/cfr.2019.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
306 Heusch G. Coronary blood flow in heart failure: cause, consequence and bystander. Basic Res Cardiol 2022;117:1. [PMID: 35024969 DOI: 10.1007/s00395-022-00909-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
307 Backhaus SJ, Lange T, George EF, Hellenkamp K, Gertz RJ, Billing M, Wachter R, Steinmetz M, Kutty S, Raaz U, Lotz J, Friede T, Uecker M, Hasenfuß G, Seidler T, Schuster A. Exercise Stress Real-Time Cardiac Magnetic Resonance Imaging for Noninvasive Characterization of Heart Failure With Preserved Ejection Fraction: The HFpEF-Stress Trial. Circulation 2021;143:1484-98. [PMID: 33472397 DOI: 10.1161/CIRCULATIONAHA.120.051542] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
308 Kammerlander AA, Nitsche C, Donà C, Koschutnik M, Dannenberg V, Mascherbauer K, Schönbauer R, Zafar A, Winter MP, Bartko PE, Goliasch G, Hengstenberg C, Mascherbauer J. Heart failure with preserved ejection fraction after left-sided valve surgery: prevalent and relevant. Eur J Heart Fail 2021. [PMID: 34506046 DOI: 10.1002/ejhf.2345] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
309 Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail 2020;22:1342-56. [PMID: 32483830 DOI: 10.1002/ejhf.1858] [Cited by in Crossref: 74] [Cited by in F6Publishing: 55] [Article Influence: 37.0] [Reference Citation Analysis]
310 Seo Y, Ishizu T, Ieda M, Ohte N; J-LONG Study Investigators. Elderly Japanese Standard Data of Echocardiography; From J-LONG study. J Echocardiogr 2020;18:175-82. [PMID: 32306373 DOI: 10.1007/s12574-020-00469-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
311 Bobenko A, Duvinage A, Mende M, Holzendorf V, Nolte K, Herrmann-Lingen C, Binder L, Düngen HD, Hasenfuss G, Pieske B, Wachter R, Edelmann F. Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction. Int J Cardiol Heart Vasc 2020;28:100525. [PMID: 32420447 DOI: 10.1016/j.ijcha.2020.100525] [Reference Citation Analysis]
312 Mann PA, Lehrke M. Cardiac substrate utilization in heart failure: Where is the relevance of SGLT2 inhibition? The Journal of Thoracic and Cardiovascular Surgery 2021. [DOI: 10.1016/j.jtcvs.2021.02.092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
313 Picano E, Ciampi Q, Cortigiani L, Arruda-Olson AM, Borguezan-Daros C, de Castro E Silva Pretto JL, Cocchia R, Bossone E, Merli E, Kane GC, Varga A, Agoston G, Scali MC, Morrone D, Simova I, Samardjieva M, Boshchenko A, Ryabova T, Vrublevsky A, Palinkas A, Palinkas ED, Sepp R, Torres MAR, Villarraga HR, Preradović TK, Citro R, Amor M, Mosto H, Salamè M, Leeson P, Mangia C, Gaibazzi N, Tuttolomondo D, Prota C, Peteiro J, Van De Heyning CM, D'Andrea A, Rigo F, Nikolic A, Ostojic M, Lowenstein J, Arbucci R, Haber DML, Merlo PM, Wierzbowska-Drabik K, Kasprzak JD, Haberka M, Camarozano AC, Ratanasit N, Mori F, D'Alfonso MG, Tassetti L, Milazzo A, Olivotto I, Marchi A, Rodriguez-Zanella H, Zagatina A, Padang R, Dekleva M, Djordievic-Dikic A, Boskovic N, Tesic M, Giga V, Beleslin B, Di Salvo G, Lorenzoni V, Cameli M, Mandoli GE, Bombardini T, Caso P, Celutkiene J, Barbieri A, Benfari G, Bartolacelli Y, Malagoli A, Bursi F, Mantovani F, Villari B, Russo A, De Nes M, Carpeggiani C, Monte I, Re F, Cotrim C, Bilardo G, Saad AK, Karuzas A, Matuliauskas D, Colonna P, Antonini-Canterin F, Pepi M, Pellikka PA, The Stress Echo Study Group Of The Italian Society Of Echocardiography And Cardiovascular Imaging Siecvi. Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging. J Clin Med 2021;10:3641. [PMID: 34441937 DOI: 10.3390/jcm10163641] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
314 von Scheidt W. Therapie der diastolischen Herzinsuffizienz (HFpEF/HFmrEF): Lichtstreifen am Horizont? Aktuelle Kardiologie 2021;10:310-5. [DOI: 10.1055/a-1506-2924] [Reference Citation Analysis]
315 Verwerft J, Verbrugge FH, Claessen G, Herbots L, Dendale P, Gevaert AB. Exercise Systolic Reserve and Exercise Pulmonary Hypertension Improve Diagnosis of Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2022;9:814601. [DOI: 10.3389/fcvm.2022.814601] [Reference Citation Analysis]
316 Boutouyrie P, Climie RE, Bruno RM. Type 2 Diabetes Mellitus, Interaction Between Left Ventricle and Large Arteries. Am J Hypertens 2022;35:388-90. [PMID: 35088827 DOI: 10.1093/ajh/hpac007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
317 Badano LP, Muraru D, Ciambellotti F, Caravita S, Guida V, Tomaselli M, Parati G. Assessment of left ventricular diastolic function by three-dimensional transthoracic echocardiography. Echocardiography 2020;37:1951-6. [PMID: 32596833 DOI: 10.1111/echo.14782] [Reference Citation Analysis]
318 Volpe M, Bauersachs J, Bayés-Genís A, Butler J, Cohen-Solal A, Gallo G, Deichl AS, Khan MS, Battistoni A, Pieske B, Saito Y, Zieroth S. Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence. Int J Cardiol 2021;327:138-45. [PMID: 33301829 DOI: 10.1016/j.ijcard.2020.11.071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
319 Seetharam K, Sengupta PP, Bianco CM. Cardiac mechanics in heart failure with preserved ejection fraction.Echocardiography. 2020;37:1936-1943. [PMID: 32594605 DOI: 10.1111/echo.14764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
320 Kapłon-Cieślicka A, Lund LH. Atrial fibrillation in heart failure with preserved ejection fraction: a risk marker, risk factor or confounder? Heart 2020;106:1949. [PMID: 33020225 DOI: 10.1136/heartjnl-2020-317978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
321 Fudim M, Ponikowski PP, Burkhoff D, Dunlap ME, Sobotka PA, Molinger J, Patel MR, Felker GM, Hernandez AF, Litwin SE, Borlaug BA, Bapna A, Sievert H, Reddy VY, Engelman ZJ, Shah SJ. Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations. Eur J Heart Fail 2021;23:1076-84. [PMID: 33886137 DOI: 10.1002/ejhf.2196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
322 Seo Y. Diagnosis of heart failure in the elderly: current status and future perspectives for echocardiographic diagnostic systems. J Med Ultrason (2001) 2022. [PMID: 35759116 DOI: 10.1007/s10396-022-01223-5] [Reference Citation Analysis]
323 Schott A, Kluttig A, Mikolajczyk R, Greiser KH, Werdan K, Sedding D, Nuding S. Association of arterial stiffness and heart failure with preserved ejection fraction in the elderly population - results from the CARLA study. J Hum Hypertens 2022. [PMID: 35581324 DOI: 10.1038/s41371-022-00703-y] [Reference Citation Analysis]
324 Mohri T, Goda A, Takeuchi K, Kikuchi H, Inami T, Kohno T, Sakata K, Soejima K, Satoh T. High prevalence of occult left ventricular diastolic dysfunction detected by exercise stress test in systemic sclerosis. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-06400-7] [Reference Citation Analysis]
325 Elsanhoury A, Nelki V, Kelle S, Van Linthout S, Tschöpe C. Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction-A Specific HFpEF Phenotype. Front Cardiovasc Med 2021;8:720690. [PMID: 34604353 DOI: 10.3389/fcvm.2021.720690] [Reference Citation Analysis]
326 Kim MN, Park SM. Heart failure with preserved ejection fraction: insights from recent clinical researches. Korean J Intern Med 2020;35:514-34. [PMID: 32392659 DOI: 10.3904/kjim.2020.104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
327 Ahmad A, Corban MT, Toya T, Verbrugge FH, Sara JD, Lerman LO, Borlaug BA, Lerman A. Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction. Eur J Heart Fail 2021;23:765-72. [PMID: 32949186 DOI: 10.1002/ejhf.2010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
328 Sharma AK, Kumar H, Razi MM, Sinha SK, Pandey U, Shukla P, Thakur R, Verma CM, Bansal RK, Krishna V. To determine the correlation between echocardiographic diastolic parameters and invasively measured left ventricular end diastolic pressure in patients with heart failure with preserved ejection fraction- an observational, descriptive study. (CEAL-HFpEF study). Indian Heart J 2021;73:470-5. [PMID: 34474760 DOI: 10.1016/j.ihj.2021.06.012] [Reference Citation Analysis]
329 Burrage MK, Hundertmark M, Valkovič L, Watson WD, Rayner J, Sabharwal N, Ferreira VM, Neubauer S, Miller JJ, Rider OJ, Lewis AJM. Energetic Basis for Exercise-Induced Pulmonary Congestion in Heart Failure With Preserved Ejection Fraction. Circulation 2021;144:1664-78. [PMID: 34743560 DOI: 10.1161/CIRCULATIONAHA.121.054858] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
330 Maeder MT, Weber L, Buser M, Brenner R, Joerg L, Rickli H. Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction. Front Cardiovasc Med 2021;8:694240. [PMID: 34307506 DOI: 10.3389/fcvm.2021.694240] [Reference Citation Analysis]
331 Wierzbowska-Drabik K, Kasprzak JD, D Alto M, Ágoston G, Varga A, Ferrara F, Amor M, Ciampi Q, Bossone E, Picano E. Reduced pulmonary vascular reserve during stress echocardiography in confirmed pulmonary hypertension and patients at risk of overt pulmonary hypertension. Int J Cardiovasc Imaging 2020;36:1831-43. [PMID: 32462450 DOI: 10.1007/s10554-020-01897-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
332 Quezada-Feijoo M, Ramos M, Lozano-Montoya I, Sarró M, Cabo Muiños V, Ayala R, Gómez-Pavón FJ, Toro R. Elderly Population with COVID-19 and the Accuracy of Clinical Scales and D-Dimer for Pulmonary Embolism: The OCTA-COVID Study. J Clin Med 2021;10:5433. [PMID: 34830715 DOI: 10.3390/jcm10225433] [Reference Citation Analysis]
333 Peteiro J, Bouzas-Mosquera A, Barbeito-Caamaño C, Martin-Alvarez E, Souto-Cainzos B, Vazquez-Rodriguez JM. Additive prognostic and diagnostic value of diastolic exercise parameters in patients referred for exercise echocardiography. Eur Heart J Cardiovasc Imaging 2022:jeac039. [PMID: 35175338 DOI: 10.1093/ehjci/jeac039] [Reference Citation Analysis]
334 Morvai-Illés B, Polestyuk-Németh N, Szabó IA, Monoki M, Gargani L, Picano E, Varga A, Ágoston G. The Prognostic Value of Lung Ultrasound in Patients With Newly Diagnosed Heart Failure With Preserved Ejection Fraction in the Ambulatory Setting. Front Cardiovasc Med 2021;8:758147. [PMID: 34926610 DOI: 10.3389/fcvm.2021.758147] [Reference Citation Analysis]
335 Tomasoni D, Adamo M, Anker MS, von Haehling S, Coats AJS, Metra M. Heart failure in the last year: progress and perspective. ESC Heart Fail. 2020;. [PMID: 33277825 DOI: 10.1002/ehf2.13124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
336 Shi K, Yang MX, Huang S, Yan WF, Qian WL, Li Y, Guo YK, Yang ZG. Effect of diabetes mellitus on the development of left ventricular contractile dysfunction in women with heart failure and preserved ejection fraction. Cardiovasc Diabetol 2021;20:185. [PMID: 34521391 DOI: 10.1186/s12933-021-01379-3] [Reference Citation Analysis]
337 Adler J, Gerhardt F, Wissmüller M, Adler C, Baldus S, Rosenkranz S. Pulmonary hypertension associated with left-sided heart failure. Curr Opin Cardiol 2020;35:610-9. [PMID: 32969856 DOI: 10.1097/HCO.0000000000000791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]